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Abstract 
Fletcher, Paige, Ph.D., August 2020                      Toxicology 
 
Investigation of Docosahexaenoic Acid as a Potential Treatment for Particulate-Induced 
Inflammation 
 
Chairperson:  Holian, Andrij, Ph.D. 
Acute and chronic inflammation are vital contributing factors to pulmonary 
diseases which can be triggered by the exposure to airborne toxicants such as crystalline 
silica (SiO2) and nanomaterials. There has been an increasing trend in the use of 
nanomaterials; specifically multi-walled carbon nanotubes (MWCNT), in various 
consumer products that in turn will increase the risk of pulmonary diseases. Unfortunately, 
there is a lack of preventative and therapeutic treatments for these diseases. A potential 
treatment that has been shown to have anti-inflammatory effects is the common dietary 
supplement docosahexaenoic acid (DHA); an omega-3 polyunsaturated fatty acid most 
commonly found in fish oil. However, the anti-inflammatory mechanisms of DHA are 
unclear in regard to particle-induced inflammation. Macrophages are important regulators 
in an immune response to inhaled foreign materials, such as SiO2 and MWCNT, in order 
to maintain homeostasis. Exposure to various particles can cause phagolysosomal 
membrane permeability (LMP) within macrophages which activates the NLRP3 
inflammasome resulting in inflammation. Macrophage functions are dependent upon 
various signaling factors which generate different macrophage phenotypes described 
broadly as classically activated, “pro-inflammatory” M1 and alternatively activated, “anti-
inflammatory” M2 as well as the additional M2 subsets. Signaling factors determine which 
macrophage phenotype is dominant to regulate the overall response to foreign particles. 
This research investigated DHA as both a prophylactic and a therapeutic treatment for 
particle-induced inflammation. The mechanisms by which DHA functions as an anti-
inflammatory dietary supplement in regard to particle-induced inflammation were assessed 
by characterizing the impact of DHA on macrophage phenotypes and LMP.  
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Chapter 1 
Introduction and Significance 
 
1.1 Particle exposure and disease 
More than one billion people worldwide suffer from either acute or chronic respiratory 
conditions which leads to respiratory diseases making up 5 of the 30 most common causes 
of death. Over one billion people inhale polluted outdoor air; therefore, contributing to this 
respiratory impairment (Forum of International Respiratory Societies, 2017). It is known 
that exposure to airborne toxicants can cause acute and chronic inflammation within the 
lungs which can lead to serious inflammatory diseases; such as lung fibrosis, and contribute 
to autoimmune diseases (Wong et al., 2016). Many occupational and man-made particles 
of specific concern have a diameter of less than 2.5 µm and can travel down into the 
alveolar regions of the lung when inhaled. These include various engineered nanomaterials 
(ENM); such as multi-walled carbon nanotubes (MWCNT), and crystalline silica (SiO2). 
The use of ENM has been rapidly increasing in many commercial products; such 
as cosmetics, electronics, and medicine (Ray et al., 2019). One of the most common ENM 
used for these products are MWCNT which are nano-sized, meaning that it has at least one 
dimension (length, width, diameter) in the size range of 1–100 nm (Yokel & MacPhail, 
2011). MWCNT are hydrophobic man-made rolled graphene sheets that have a high 
surface area per mass (Saifuddin et al., 2013). However, some MWCNT have been linked 
to lung fibrosis similar to that produced by chrysotile asbestos as well as granuloma 
formations ( Yokel & MacPhail, 2011; Lam et al., 2006). 
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In contrast to the nanosized MWCNT, SiO2 is a micron-sized particle primarily 
generated in occupational settings such as mining, manufacturing, and construction. It is 
considered hydrophilic and commonly found in nature as quartz which can be fractured to 
a respirable size of <10 μm (Dyachenko et al., 2004; Pollard, 2016). Exposure to inhalable 
SiO2 particles are known to cause silicosis; an established world-wide occupational health 
problem, and autoimmune disorders (Pollard, 2016). Understanding the mechanisms of 
lung inflammation and the development of preventative and therapeutic treatments to 
reduce inflammation caused by either of these particles are currently lacking within this 
field.  
 
1.2 Polyunsaturated fatty acids 
Two important families of polyunsaturated fatty acids (PUFA) are omega-6 and omega-3. 
Foods high in omega-6 PUFAs are vegetable oils, red meat, and dairy. Omega-3 PUFAs 
are high in salmon, tuna, and walnuts. Omega-6 and omega-3 PUFAs encompass the 
essential fatty acids of linoleic and α-linolenic acids; respectively. These two fatty acids 
are considered to be essential since they cannot be synthesized in animals. (Calder, 2017; 
Molendi-Coste et al., 2011; Swanson et al., 2012). These essential fatty acids are converted 
into other fatty acids within each PUFA family such as arachidonic (ARA) and 
docosahexaenoic (DHA) acids through various desaturation and elongation steps (Calder, 
2017). 
The linoleic essential fatty acid is usually the most prevalent PUFA in the human 
diet partly due to the fact that plants produce much more of it than of α-linolenic acid. 
Unfortunately, in most Western diets there is too much omega-6; in part due to high levels 
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of consumption of red meat, and not enough of omega-3 which can be improved with 
consumption of fatty fish. This diet leads to an omega-6/-3 ratio of 10-20/1 where most 
adults intake less than 0.2 g/day of DHA (Calder, 2017; Molendi-Coste et al., 2011). 
Increased ARA content is linked to inflammation while exposure to omega-3 PUFAs; 
specifically DHA, has been shown to have various anti-inflammatory capabilities (Calder, 
2017; Swanson et al., 2012). 
 
1.2.1 Docosahexaenoic acid (DHA) 
It has been reported that there has been a 60% increase between 2007 and 2012 in the 
dietary intake of fish oil supplementation which is high in DHA (Clarke et al., 2015). DHA 
is a long-chain, highly unsaturated omega-3 fatty acid that consists of 22 carbons and 6 cis 
double bonds (22:6). This allows the structure of DHA to twist, resulting in a low melting 
point. It is often found linked into a more complex lipid structure, such as a phospholipid. 
DHA is an important component of all cell membranes and is mainly found in the brain 
and retina (Calder, 2016). 
Studies have shown that DHA is beneficial throughout life; such as improving 
cognitive capabilities during fetal development and improving outcomes for cardiovascular 
disease and Alzheimer’s disease (Devassy et al., 2016; Swanson et al., 2012). However, 
assessing the impact of DHA as a potential treatment in regard to particle-induced 
inflammation is limited. Evidence has suggested that omega-3 PUFAs decreased particle-
induced inflammation in both C57BL/6 wild-type mice; which are Th1-prone, and in a 
transgenic Fat-1 murine model with a C57BL/6 background (X.-Y. Li et al., 2017; 
Watanabe et al., 2004). It has also been shown that DHA blocked SiO2-triggered 
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autoimmunity in autoimmune disease-prone NZBWF1 mice (Bates et al., 2016). The anti-
inflammatory mechanisms of DHA in regard to particle-induced inflammation within a 
Balb/c murine model; which are Th2-prone (Watanabe et al., 2004), are not fully 
understood. 
 
1.3 Phagolysosomal membrane permeability (LMP) 
Pulmonary macrophages are responsible for maintenance of homeostatic conditions within 
the lungs. This includes regulating immune responses to inhaled foreign materials; such as 
exposure to MWCNT or SiO2, by phagocytosing these foreign substances and processing 
them for elimination. Macrophages can’t clear these particles and their persistence in the 
lung can lead to inflammation that can progress to fibrosis and systemic diseases (Byrne et 
al., 2015). Inflammation induced by macrophages is initiated by activation of two signals: 
1) the NF-B pathway and 2) the NLRP3 inflammasome (Schroder & Tschopp, 2010). 
The first signal is responsible for priming the cell. Various pathogen-associated 
molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) can 
trigger activation of the NF-B pathway. NF-B is responsible for the formation of pro-
IL-1 and components of the NLRP3 inflammasome (Lamkanfi & Dixit, 2014; Martínez-
Micaelo et al., 2016; Schroder & Tschopp, 2010). This is an essential step; however, the 
current research focuses more on the second signal in regard to particle-induced 
inflammation. 
The activation signal is the second signal which promotes conformational changes 
to prompt the assembly of the NLRP3 inflammasome. There is a cascade of events that 
occurs before activation of signal 2. Particles are phagocytosed by alveolar macrophages 
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(AM) and become engulfed in a phagosome which comes together with a lysosome to form 
a phagolysosome. This phagolysosome is where foreign material is intended to be degraded 
in order to maintain homeostasis. However, non-degradable particles, such as MWCNT 
and SiO2, can cause phagolysosomal membrane permeability (LMP). The occurrence of 
LMP leads to the release of various proteases into the cytosol; such as cathepsins and 
cathepsin B in particular. Cathepsin B has been reported to activate the NLRP3 
inflammasome which in turn cleaves pro-caspase-1 into active caspase-1 causing pro-IL-
1 processing into its mature form of IL-1 for secretion. This results in various 
inflammatory signaling cascades to ensue (Lamkanfi & Dixit, 2014; Martínez-Micaelo et 
al., 2016; Schroder & Tschopp, 2010; Strowig et al., 2012).  
 
1.4 Macrophage phenotype 
Macrophages are phenotypically complex and subject to their environment, such that their 
functions and contribution to inflammation are dependent upon various signaling factors. 
These stimuli; both intercellular and extracellular signaling, determine which macrophage 
phenotype is dominant to regulate the overall response to foreign particles. Depending on 
the overall environment present during particle exposure, macrophages could either be 
aiding in inflammation or suppressing inflammation through phenotype shifts. There is 
always a mixture of macrophage phenotypes present which could be representing hybrid 
phenotypes rather than individually-defined phenotypes; however, the overall response is 
expected to be based upon the dominant phenotype (Byrne et al., 2015; Italiani & Boraschi, 
2014; Labonte et al., 2014). 
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The most common paradigm is the “M” classification which was named to reflect 
the Th1/Th2 polarization. There are two main phenotypes of macrophages that are broadly 
defined as the classically activated, “pro-inflammatory” M1 and the alternatively activated, 
“anti-inflammatory” M2. The M2 phenotype also has additional subsets of M2a, M2b, 
M2c, and M2d (Labonte et al., 2014). Most research assesses the roles of the M1 and M2a 
phenotypes. The M1 phenotype is considered a Th1-like response with type I 
inflammation. It is induced by IFNγ or LPS and express high levels of IL-12, iNOS, IL-1β 
and TNFα. The M2a phenotype is considered more of a Th2-like response with type II 
inflammation and allergy. It is induced by IL-4 or IL-13 and express high levels of YM1, 
CD206, and FIZZ1. All of the M2 subsets have overlapping similarities of a Th2-like 
response and produce high levels of IL-10; however, they are individually complex. The 
M2b phenotype has overlapping characteristics with the M1 phenotype as well and is 
labeled as “type II – activated”. It is induced by immune complexes and TLR/IL-1R ligands 
and express high levels of CCL1, LIGHT, and SPHK1. The M2c phenotype is labeled as 
“deactivated” with overlapping characteristics with the M2a phenotype and is involved in 
matrix deposition and tissue remodeling. It is induced by IL-10, TGF-β, or glucocorticoids 
and produce high levels of CD163, TLR8, and TGF-β. There is also the M2d subset which 
is labeled as “tumor-associated macrophages” (TAMs) and have high levels of VEGF 
which promotes tumor growth and metastasis. (Tomioka, 2016; Jiang & Zhu, 2016; 
Hesketh et al, 2017; Mantovani et al, 2004). 
Understanding the contributions of the M1 and M2 macrophage phenotypes is 
crucial to assessing the inflammatory effects of particles since macrophages are an essential 
cell that regulates the innate immune response to inhaled foreign particles. The actual 
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contributions of M1 and M2 macrophages in disease progression are not fully established. 
Furthermore, the mechanisms of the formation of the various M2 subsets, especially M2b 
and M2c, are not well-defined in regard to particle-induced inflammation. 
 
1.5 Research motivation 
The objectives of the current studies were to evaluate the ability of DHA to reduce 
pulmonary inflammation caused by MWCNT and SiO2, both as a potential prophylactic 
and a therapeutic treatment. The use of the two different particles provided the opportunity 
to examine the effects of DHA on particles with reported differences in immune 
mechanisms (Ray et al., 2019) within time courses that represented both moderate and high 
levels of particle doses. A Balb/c murine model; which is considered more Th2 prone 
(Watanabe et al., 2004), was used since research on DHA treatment is currently limited for 
this murine model. In addition to typical markers of lung inflammation; such as 
cytotoxicity, the occurrence of LMP, and lung histopathology, the shifts in macrophage 
phenotype were also assessed. 
Each chapter contributes to a better understanding of DHA as a potential treatment 
for particle-induced inflammation. The aim of Chapter 3 was to assess the differences 
between the responses of the macrophage phenotypes in regard to particle exposure and a 
prophylactic DHA treatment in vitro. Chapter 3 also evaluated if the in vitro outcomes 
translated to in vivo effects for an acute particle exposure model. In order to get a better 
understanding on the effects of DHA treatment within the Balb/c murine model, Chapter 4 
aimed to assess DHA as a potential prophylactic treatment for a semi-acute and a chronic 
in vivo particle exposure model. Most research on DHA treatment is assessing it as a 
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prophylaxis, but research of DHA as a possible therapeutic is scarce. In reality, treatment 
to inflammatory diseases typically occurs after inflammation has ensued. Therefore, 
Chapter 5 evaluated DHA as a potential therapeutic treatment after semi-acute and chronic 
in vivo particle exposure models. 
The overall hypothesis is that DHA downregulates the inflammatory response of 
macrophages in response to particle-induced inflammation, but this response is not uniform 
across the different macrophage phenotypes. The anti-inflammatory activity of DHA 
occurs by a combination of altering LMP and shifting macrophage phenotype. In addition, 
the effects of DHA will be more effective in treating MWCNT than SiO2 in the Balb/c 
murine exposure model. 
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Chapter 2 
Materials and Methods 
 
2.1 in vitro experimental procedures 
2.1.1 Particle Preparations 
Preparations and characteristics of a highly inflammatory multi-walled carbon nanotube 
[MWCNT; provided by the National Toxicology Program at NIEHS (Hamilton et al., 2012; 
labeled as FA21)] and acid-washed crystalline SiO2 (SiO2; Min-U-Sil-5, Pennsylvania 
Glass Sand Corp.; Pittsburgh, PA, USA) are as previously described (Hamilton et al., 2012, 
p. 3; Thakur et al., 2009). Briefly, both particles were prepared fresh in PBS/7.5% bovine 
serum albumin solution (A8412, Sigma-Aldrich; St. Louis, MO, USA). Particle 
suspensions were sonicated (550 watts, 20 kHz, 1 minute, 35% amplitude) in a cup-horn 
sonicator. Stock concentrations were 5 mg/mL and experimental concentrations were 50 
µg/mL. 
 
2.1.2 Isolation of Alveolar Macrophages 
Both male and female wild type Balb/c mice were euthanized by a lethal dose of sodium 
pentobarbital (150 mg/kg, EuthasolTM) by intraperitoneal injection; a method consistent 
with the American Veterinary Medical Association guidelines. This method of euthanasia 
causes minimal distress to the mice along with ensuring no injury to the lungs. Cells within 
the lungs were isolated by performing whole lung lavages with ice-cold PBS as previously 
described (Hamilton et al., 2012; Jessop & Holian, 2015). Briefly, the lungs were removed 
from the body, lavaged, and pooled together to obtain optimal cell yields. Lung lavaged 
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cells were isolated by centrifugation (400 x g, 5 min, 4°C) and cell counts were obtained 
via Coulter Z2 particle counter (Beckman Coulter; Brea, CA, USA). This process was 
repeated several times to establish n=3 for in vitro experimental replicates. 
 
2.1.3 Cell Culture and Polarization of Macrophage Phenotypes 
Isolated alveolar macrophages were suspended in RPMI-1640 media (Corning; Corning, 
NY, USA) supplemented with 10% fetal bovine serum (VWR; Radnor, PA, USA), 1% 
penicillin-streptomycin (Corning) and 1% sodium pyruvate (Corning). Cells were 
suspended at 1x105 cells/well with 100 µL/well for 96-well plate formats, 2x105 cells/well 
with 400 µL/well for 24-well plate formats, and 5x105 cells/well with 3 mL/well for 6-well 
plate formats. For macrophage phenotype polarization, lavaged cells were polarized into 
the different phenotypes and incubated at 37°C in a 5% CO2 incubator for 24-hours as 
follows: M1 (20 ng/mL IFNγ [PeproTech; Rocky Hill, NJ, USA] + 10 pg/mL LPS) (Genin 
et al., 2015), M2a (20 ng/mL IL-4 [PeproTech] + 20 ng/mL IL-13 [PeproTech]) (Genin et 
al., 2015), M2b (immune complex; IC, consisting of 150 μg/mL anti-chicken egg albumin 
antibody [Sigma-Aldrich] + 15 μg/mL chicken egg white albumin [Sigma-Aldrich]), 
incubated at 37°C for 30 minutes to form IC, and then 50 ng/mL LPS was added) (Yue et 
al., 2017), or M2c (20 ng/mL IL-10 [eBioscience; San Diego, CA, USA] + 20 ng/mL TGF- 
β [R&D Systems; Minneapolis, MN, USA]) (Zizzo, et al., 2012; Kim, et al., 2019). 
Treatments for each experiment are described below. 
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2.1.4 Cytotoxicity Assays 
For macrophage phenotype cytotoxicity experiments, isolated alveolar macrophages were 
polarized and plated in 96-well plates for 24-hours at 37°C (as described above). After 24-
hours the phenotype media was aspirated, cells were washed with PBS, and cells were 
given RPMI media (described above) supplemented with either vehicle (control volume of 
100% EtOH) or docosahexaenoic acid [DHA; 25 μM, Cayman Chemical; Ann Arbor, MI, 
USA (Wierenga et al., 2019; Wiesenfeld et al., 2001)] for 48-hours at 37°C. Particles 
(MWCNT or SiO2, 50 µg/mL) and LPS for priming (20 ng/mL) were added to the cells for 
24-hours at 37°C. For EtOH vs BSA cytotoxicity experiments, isolated alveolar 
macrophages were plated in a 96-well plate format and supplemented with either vehicle 
(control volume of 100% EtOH or BSA) or DHA (25 μM, Cayman Chemical) for 48-hours 
at 37°C. DHA was either suspended with 100% EtOH or conjugated with BSA [provided 
by Dr. Pestka at Michigan State University; East Lansing, MI, USA (Wierenga et al., 
2019)]. Particles (MWCNT or SiO2, 50 µg/mL) and LPS (20 ng/mL) were added to the 
cells for 24-hours at 37°C. Cell damage was determined by various cellular cytotoxicity 
assays (CytoTox 96 cytotoxicity assay or CellTiter96® AQueous one solution cell 
proliferation assay,  Promega; Madison, WI, USA) and IL-1β release (mouse IL-1β DuoSet 
ELISA, R&D Systems) according to manufacturer’s protocols. 
 
2.1.5 Particle Uptake & Flow Cytometry 
Isolated alveolar macrophages were polarized and plated in 6-well plates for 24-hours at 
37°C (as described above). After 24-hours the phenotype media was aspirated, cells were 
washed with PBS, and cells were given RPMI media (described above) supplemented with 
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either vehicle (control volume of 100% EtOH) or DHA (25 μM) for 24-hours at 37°C. 
Particles (MWCNT or SiO2, 50 µg/mL) and LPS (20 ng/mL) were added to the cells for 4-
hours at 37°C. Particle uptake was determined by flow cytometry on the Attune® NxT 
Acoustic Focusing Cytometer (Life Technologies; Carlsbad, CA, USA) in the Flow 
Cytometry Core at the University of Montana by using changes in side scatter (SSC) and 
anti-mouse antibody F4/80-PE/Cy7 (clone BM8, Biolegend; San Diego, CA, USA) to 
identify alveolar macrophages. Data analysis was performed in FlowJo 10.6 (BD; Franklin 
Lakes, NJ, USA). 
 
2.1.6 Phagolysosomal Membrane Permeability (LMP) Assay 
Isolated alveolar macrophages were polarized and plated in 24-well plates for 24-hours at 
37°C (as described above). After 24-hours the phenotype media was aspirated, cells were 
washed with PBS, and cells were given RPMI media (described above) supplemented with 
either vehicle (control volume of 100% EtOH) or DHA (25 μM) for 24-hours at 37°C. 
Particles (MWCNT or SiO2, 50 µg/mL) and LPS (20 ng/mL) were added to the cells for 4-
hours at 37°C. LMP was assessed using methods modified from Aits et al. (Aits et al., 
2015) as previously described (Jessop et al., 2017). Briefly, cells were washed twice with 
PBS and incubated with 200 µL cytosol extraction buffer (250 mM sucrose, 20 mM Hepes, 
10 mM KCl, 1.5 mM MgCL2, 1 mM EDTA, 1 mM EGTA, 0.5 mM pefabloc, + digitonin) 
on ice for 15 minutes while rocking. The digitonin concentrations for optimal cytosolic 
fraction extraction was obtained previously via titrations of Balb/c alveolar macrophages 
(M0 = 12.5 µg/mL, M1 & M2a = 17 µg/mL, M2b = 25 µg/mL, and M2c = 22.5 µg/mL). 
β-N-acetylglucosaminidase (NAG) activity was measured by adding 30 µL cytosolic 
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extract to 100 µL of NAG buffer (0.2 M sodium citrate and 300 µg/mL 4-
methylumbelliferyl-2-acetamido-2-deoxy-β-D-glucopyranoside) and read on a plate reader 
(20 minutes, 45 second intervals, 356 nm excitation, 444 nm emission). Lactate 
dehydrogenase (LDH) activity was measured according to the manufacturer’s protocol 
(CytoTox 96 cytotoxicity assay, Promega) and used as an internal control to which NAG 
activity was normalized.  
 
2.2 in vivo experimental procedures 
2.2.1 Particle Preparations  
Preparations and characteristics of MWCNT and SiO2 particles are the same as described 
above. Briefly, both particles were prepared fresh in dispersion media vehicle (DM; 0.6 
mg/mL mouse serum albumin [Sigma-Aldrich] and 0.01 mg/mL 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine [Sigma-Aldrich] in PBS). The particle suspensions were 
sonicated (550 watts, 20 kHz, 5 minutes, 35% amplitude) in a cup-horn sonicator.  
 
2.2.2 Mice and Diets 
Both male and female wild type Balb/c mice, 6-8 weeks old, were used in equal numbers. 
The number of mice used for each experiment are depicted within each figure legend. The 
mice were maintained in microisolation containers within the BSL-2 Laboratory Animal 
Resources facility at the University of Montana in the accordance with the Guide for the 
Care and Use of Laboratory Animals. The animal room is programmed on a 12-hour 
light/dark cycle at approximately 18-26C with food and water provided ad libitum. The 
animals were monitored on a daily basis and weighed once a week. The animal care facility 
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at the University of Montana is staffed with full-time veterinarians that are AAALAC 
accredited. The animal use protocols were in accordance with the University of Montana 
Institutional Animal Care and Use Committee. Please note that sex comparisons were not 
performed due to too low of numbers for each sex separately; therefore, males and females 
were pooled together within each group for analysis. 
 Formulations of experimental diets are summarized in Table 1. Briefly, modified 
American Institute of Nutrition (AIN)-93G powdered diet (Dyets, Inc.; Bethlehem, PA, 
USA) containing 70 g/kg fat was prepared with 10 g/kg food-grade corn oil (Wesson Pure 
100% Natural Corn Oil, Amazon; Seattle, WA, USA) to provide essential fatty acids. The 
control diet contained 60 g/kg food-grade oleic safflower oil (Oleico Natural Safflower Oil, 
Walmart; Bentonville, AR, USA). The oleic safflower oil was replaced with 25 g/kg 
microalgal oil containing 40% DHA (DHASCOTM, Martek Biosciences Corp., provided 
by Dr. Pestka at Michigan State University; East Lansing, MI) which corresponded to 1% 
(w/w) DHA. This dosage was chosen to represent a relevant human dietary intake of 5 
g/day and was conducted in collaboration with Dr. Pestka in a similar manner as previously 
described (Bates et al., 2016). The European Food Safety Authority deemed supplements 
containing 5 g/day omega-3 polyunsaturated fatty acids from microalgal oil safe for human 
consumption (EFSA NDA Panel, 2014). All diets were changed every 48-hours to prevent 
oxidation. Confirmation of fatty acid composition within red blood cells was sent for 
analysis [Dr. Pestka’s laboratory at Michigan State University (prophylactic semi-acute 
study in Chapter 4 only), East Lansing, MI, USA; or OmegaQuant (all other mouse 
studies); Sioux Falls, SD, USA] which are described within each chapter separately. 
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Table 1. Formulations of experimental diets. 
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2.2.3 Experimental Designs 
The overall study designs are described and graphically depicted within each chapter 
separately. For each mouse study, Balb/c mice were fed either a control or 1% DHA-
containing diet (25 g/kg). Prior to each particle instillation the mice were anesthetized with 
isoflurane (5%, inhaled) so as not to use any restraints or cause distress and then 
oropharyngeal instilled with either DM-only vehicle (50 µl/mouse), MWCNT (50 
µg/mouse), or SiO2 (1 mg/mouse). The mice were euthanized by a lethal dose of sodium 
pentobarbital (150 mg/kg, EuthasolTM) by intraperitoneal injection; a method consistent 
with the American Veterinary Medical Association guidelines. This method of euthanasia 
causes minimal distress to the mice along with ensuring no injury to the lungs. 
 
2.2.4 Isolation of Pulmonary Cells 
Cells within the lungs were isolated by performing lung lavages and assessed as previously 
described (Burmeister et al., 2019; Jessop & Holian, 2015). Briefly, the lungs were 
removed from the body and lavaged with ice-cold PBS to obtain optimal cell yields. The 
first pull (instillation of 0.5 mL of ice-cold PBS, withdrawn, then the same fluid repeated 
twice more) consisted of the most concentrated lung lavage fluid (LLF). Lung lavaged cells 
were isolated by centrifugation (400 x g, 5 min, 4°C) and cell counts were obtained via 
Coulter Z2 particle counter (Beckman Coulter; Brea, CA, USA). Cells were stained for 
differential analysis via Wright-Geimsa stain in a Hematek 2000 autostainer (Miles-Bayer-
Siemens Diagnostics; Deerfield, IL, USA). Alveolar macrophages (AM) within the LLF 
were isolated and cultured ex vivo in RPMI-1640 media (Corning; Corning, NY, USA) 
supplemented with 10% heat-inactivated fetal bovine serum (VWR; Radnor, PA, USA), 
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1% penicillin-streptomycin (Corning) and 1% sodium pyruvate (Corning) for 24-hours at 
37°C with LPS for priming (20 ng/mL) to assess IL-1β levels within the supernatant. 
 
2.2.5 Analysis of Cell Damage and Inflammatory Mediators 
Cell damage and inflammatory markers were assessed within LLF of the mice. Cell 
damage was determined by release of LDH (CytoTox 96 cytotoxicity assay, Promega) and 
protein concentration (Pierce BCA protein assay, Thermo Fisher Scientific; Waltham, MA, 
USA) according to manufacturer’s instructions. Inflammatory cytokines were assessed by 
using a customized MesoScale Discovery U-PLEX assay platform (IFNγ, IL-1β, TNFα, 
IL-33, IL-6, IL-10, IL-13; Meso Scale Diagnostics LLC; Rockville, MD, USA) according 
to manufacturer’s instructions. LMP was determined by total cathepsin (Z-LR-AMC 
fluorogenic peptide substrate, R&D Systems) and cathepsin B release (cathepsin B 
inhibitor II - Calbiochem, Millipore Sigma; Burlington, MA, USA) within the LLF and IL-
1β release (mouse IL-1β DuoSet ELISA, R&D Systems) within the supernatants of isolated 
ex vivo AM. 
 
2.2.6 Macrophage Phenotype Analysis 
Macrophage phenotype was assessed within lung and spleen tissues. Sections of the tissues 
were snap-frozen on the day of harvest and RNA was isolated (TRIzol®, Thermo Fisher 
Scientific) according to manufacturer’s instructions. All RNA was converted to cDNA 
(iScript RT Supermix, Bio-Rad; Hercules, CA, USA) and qPCR analysis was performed 
(SsoAdvanced Univ. SYBR Green Supermix, Bio-Rad) according to manufacturer’s 
instructions to determine macrophage phenotype: M1 [CXCL10, IL-1β, TNFα, iNos (Dong 
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& Ma, 2018; Genin et al., 2015; Hesketh et al., 2017; Jiang & Zhu, 2016; Labonte et al., 
2014; Ohama et al., 2015; Tomioka, 2016; Mantovani et al, 2004)], M2a [FN1, CD206, 
Fizz1, YM1 (Dong & Ma, 2018; Genin et al., 2015; Hesketh et al., 2017; Jiang & Zhu, 
2016; Labonte et al., 2014; Tomioka, 2016)], M2b [CCL1, LIGHT, CXCL3, SPHK1 
(Edwards et al., 2006; He et al., 2013; Hesketh et al., 2017; Jiang & Zhu, 2016; Labonte et 
al., 2014; Ohama et al., 2015; Tomioka, 2016; Mantovani et al, 2004)], and M2c [CD163, 
CXCL13, TIMP1, TLR8 (Hesketh et al., 2017; Jiang & Zhu, 2016; Koscsó et al., 2013; 
Labonte et al., 2014; Ohama et al., 2015; Tomioka, 2016; Mantovani et al, 2004)]. All 
qPCR primers with associated positive controls and reference genes used were validated 
PrimePCR SYBR Green assays from Bio-Rad. All signals were collected via 384-well 
CFX Maestro (Bio-Rad, supplied by Dr. Patel at FYR Diagnostics, Missoula, MT and Dr. 
Kreitinger at Dermaxon, Missoula, MT, USA) and levels were normalized to reference 
gene β-2 microglobulin (B2m; ΔCq). Relative gene expressions of MWCNT and SiO2 of 
control-fed mice were normalized to DM-only of control-fed mice (ΔΔCq) to assess particle 
effect. The relative gene expressions of DM-only, MWCNT, and SiO2 of the 1% DHA-fed 
mice were normalized to DM-only, MWCNT, and SiO2 of the control-fed mice; 
respectively, (ΔΔCq) to assess diet effect. The ΔΔCq values were analyzed within a heat-
map. A dominant phenotype shift was indicated by an upregulation of gene expression of 
at least three of the four genes within each phenotype or a trending increase indicated by 
upregulation of two of the four genes.   
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2.2.7 Histopathology 
Lungs from each mouse were inflation-fixed through the trachea with 3% 
paraformaldehyde-PBS and placed in this same fixative overnight at 4°C. The lungs were 
washed with ice-cold PBS, dehydrated with 70% EtOH, and paraffin-embedded. Tissue 
sections (5 µm) were stained with either Gömöri (prophylactic semi-acute study in Chapter 
4 only) or Masson’s (all other mouse studies) trichrome for histological analysis. Mouse 
lung sections were imaged at 10x using Nikon E 800 epi-fluorescent/transmitted light 
microscope with Olympus DP71 camera and CellSens software in the Molecular Histology 
and Fluorescence Imaging Core at the University of Montana. 
The lung tissues were scored in a blinded fashion by either a board-certified 
veterinary pathologist (Dr. Jack Harkema, Michigan State University; prophylactic semi-
acute study in Chapter 4 only) or two observers separately (all other mouse studies) with 
three mice per treatment group. The degree of lung disease visible within the lung sections 
were scored using a 5-point scale system (0, 1, 2, 3, 4) for the percentage of total pulmonary 
tissue effected with (0) being no effect, (1) minimal (<10 %), (2) slight (10 – 25 %), (3) 
moderate (26 – 50 %), and (4) severe (51 – 75 %) lung pathology by assessing collagen 
deposition, extracellularity, inflammation, lesion formation, particle encapsulation, and 
airway thickening. For the mouse studies where two observers scored the pathology 
separately, Cronbach’s-α was used to assess reliability between scorers where inter-rater 
reliability was significant at 0.956 indicating agreement between the scores of the two 
observers. The values shown are the median of the two scorers’ values. Lung airway 
thickness was measured on the iCys Laser Scanning Cytometer (ThorLabs; Newton, NJ, 
USA) in the Fluorescence Cytometry Core at the University of Montana. Six airways with 
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four measurements per airway in duplicate lung sections per mouse were measured with 
three mice per treatment group.   
 
2.3 Statistical Analysis 
Depending on the data type, data had to undergo a log-transformation in order to equalize 
the variance, followed by a parametric one- or two-way analysis of variance (ANOVA) 
and post hoc mean comparison (Holm-Sidak). Data was expressed as mean ± SEM with 
0.05 significance level. Subjective histopathology scoring is ordinal level data; therefore, 
raw scores were rank-transformed prior to ANOVA and post hoc analysis. Graphics and 
analyses were performed on PRISM 8.3.1 (GraphPad; San Diego, CA, USA). 
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Chapter 3 
DHA impacts macrophage phenotype and LMP with particle 
exposure in vitro and an acute particle exposure in vivo 
 
3.1 Abstract 
Inhalation of certain particles can cause acute and chronic pulmonary inflammation; 
however, treatments are currently lacking within this field. Docosahexaenoic acid (DHA) 
is an omega-3 polyunsaturated fatty acid that has been reported to have various anti-
inflammatory capabilities. Since the anti-inflammatory mechanisms of DHA are unclear 
for particle-induced inflammation, this study tested the hypothesis that DHA 
downregulates the inflammatory response of macrophages in response to particles by a 
combination of altering phagolysosomal membrane permeability (LMP) and shifting 
macrophage phenotype. Balb/c primary alveolar macrophages (AM) were isolated and 
polarized into M1, M2a, M2b, or M2c macrophage phenotypes in vitro, treated with DHA, 
and exposed to either a multi-walled carbon nanotube or crystalline silica to assess 
cytotoxicity, particle uptake, and LMP. Results demonstrated that DHA could be pro-
inflammatory or anti-inflammatory depending on the particle exposure. There were 
minimal effects for cytotoxicity, a more robust effect for particle uptake with silica, and 
differences in LMP between the phenotypes. However, DHA appeared to beneficially 
impact the M2c phenotype with particle exposure the most. To determine if DHA affected 
particle-induced inflammation in a similar manner in vivo, Balb/c mice were placed on a 
control or 1% DHA diet for 3 weeks, instilled with the same particles, and euthanized 24-
hours after particle exposure. Results indicated that in contrast to the in vitro studies, DHA 
 22 
increased pulmonary inflammation, increased LMP, and shifted macrophage phenotype 
when exposed to particles. These findings suggest that DHA may have had an increased 
effect on other pulmonary cells at this acute timepoint rather than AM, which could account 
for the increased inflammatory response. 
 
3.2 Introduction 
Exposure to airborne particles can cause acute and chronic inflammation in the lungs which 
can lead to serious inflammatory diseases, such as lung fibrosis, and contribute to 
autoimmune diseases. Understanding the mechanisms of lung inflammation and 
development of preventative and therapeutic treatments are lacking in this field (Wong et 
al., 2016). One possible treatment that has been shown to have anti-inflammatory effects 
is an omega-3 polyunsaturated fatty acid; docosahexaenoic acid (DHA) (Serhan et al., 
2008), which is found in fish oil. It has been reported that there has been a 60% increase 
between 2007 and 2012 in the dietary intake of fish oil supplementation; however, it’s anti-
inflammatory mechanisms are not fully understood (Clarke et al., 2015). Current research 
using DHA as a potential treatment for particle-induced inflammation is scarce, but there 
is evidence that shows omega-3 polyunsaturated fatty acids can suppress particle-induced 
pulmonary and systemic inflammation (X.-Y. Li et al., 2017; Bates et al., 2016).  
Alveolar macrophages regulate the immune response to various inhaled foreign 
particles (such as multi-walled carbon nanotubes; MWCNT, and crystalline silica; SiO2). 
Macrophages phagocytose these foreign particles and attempt to process them for 
elimination in order to maintain both homeostasis and a sterile environment within the 
lung. Macrophages can’t degrade these particles and their persistence in the lung can lead 
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to inflammation that can progress to fibrosis and systemic diseases (Byrne et al., 2015). 
Inflammation induced by macrophages is initiated by activation of two signals: 1) 
activation of the NF-B pathway and 2) assembly of the NLRP3 inflammasome (Schroder 
& Tschopp, 2010). The NF-B pathway is responsible for the formation of pro-IL-1 and 
components of the NLRP3 inflammasome (Lamkanfi & Dixit, 2014; Martínez-Micaelo et 
al., 2016; Schroder & Tschopp, 2010). Before activation of signal 2 occurs, there is a 
cascade of events that happen: environmental stimuli (such as phagocytosed particles) 
induce phagolysosomal membrane permeability (LMP) causing the release of various 
proteases into the cytosol, one being cathepsin B. Cathepsin B has been reported to activate 
the NLRP3 inflammasome which in turn cleaves pro-caspase-1 into active caspase-1 
causing pro-IL-1 processing into its mature form of IL-1 for secretion (Lamkanfi & 
Dixit, 2014; Martínez-Micaelo et al., 2016; Schroder & Tschopp, 2010; Strowig et al., 
2012).  
However, macrophages are phenotypically complex and subject to their 
environment, such that their functions and contribution to inflammation are dependent 
upon various signaling factors. These stimuli will determine what macrophage phenotype 
is present under any given situation, which regulates the overall macrophage response to 
foreign particles. There is always a mixture of macrophage phenotypes present; however, 
the overall response is expected to be based upon the dominant phenotype. There are two 
main phenotypes of macrophages that are broadly defined as the classically activated, “pro-
inflammatory” M1 and the alternatively activated, “anti-inflammatory” M2. The M2 
phenotype also has additional subsets of M2a, M2b, M2c, and M2d/tumor-associated 
macrophages (Byrne et al., 2015; Italiani & Boraschi, 2014; Labonte et al., 2014). The 
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regulation of the M1 and M2 macrophage phenotype balance is crucial to understand the 
outcome of particle-induced inflammation. Depending on the overall environment present 
during particle exposure, macrophages could either be aiding in inflammation or 
suppressing inflammation through phenotype shifts. The actual contributions of M1 and 
M2 macrophages in disease progression are not fully established and likely depend on 
specific diseases. Furthermore, the mechanisms of the formation of the various M2 subsets, 
especially M2b and M2c, are not well-defined in regard to particle-induced inflammation. 
The hypothesis in this chapter is that DHA downregulates the inflammatory 
response of macrophages in response to particle-induced inflammation, but that the 
response is not uniform across the different macrophage phenotypes. The anti-
inflammatory activity of DHA occurs by a combination of altering LMP and shifting 
macrophage phenotype. To test this hypothesis, in vitro studies were conducted using 
freshly isolated alveolar macrophages from Balb/c mice that were polarized into the 
different phenotype subsets and evaluated for responses to MWCNT and SiO2 in the 
presence or absence of DHA. Additional in vivo studies were conducted using Balb/c mice 
that were fed a prophylactic 1% DHA diet compared to a control diet, instilled with these 
same particles, and examined for in vivo inflammation and phenotypic changes. 
 
3.3 Results 
3.3.1 Cytotoxicity assessments of DHA in vitro 
Understanding the contributions of the individual M1 and M2 macrophage phenotypes is 
crucial to assessing the inflammatory effects of particles since macrophages are an essential 
cell that regulates the innate immune response to inhaled foreign particles. The impacts on 
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the various M2 subsets, especially M2b and M2c, are not well-defined in regard to particle-
induced inflammation. Therefore, the effects of particle exposure and DHA treatment was 
assessed in order to determine the response differences between each macrophage 
phenotype. A number of techniques have been used to add DHA to cells in vitro which is 
most often either bound with BSA or suspended with EtOH and also varies between cell 
type (Martínez-Micaelo et al., 2016; Wiesenfeld et al., 2001; Williams-Bey et al., 2014). 
Therefore, initial studies were conducted to assess the effects of DHA on particle exposure 
to compare EtOH and BSA vehicles using Balb/c alveolar macrophages (AM). The results 
showed that when AM were exposed to MWCNT, the treatment groups had similar cell 
viability (Figure 1A); however, there was a significant decrease in IL-1β release from these 
same cells when comparing DHA-EtOH to both EtOH-only and DHA-BSA treatments 
(Figure 1B). There was a significant improvement in cell viability with AM treated with 
DHA-EtOH when exposed to SiO2 compared to EtOH-only and DHA-BSA as shown in 
Figure 1A. This was further supported by a significant decrease in IL-1β release of these 
treatment groups from these same cells (Figure 1B). Therefore, initial studies concluded 
that the use of EtOH instead of BSA in vitro for the DHA vehicle with Balb/c AM resulted 
in the least toxicity. Literature findings supported these results in other cell types and 
confirmed that an in vitro DHA concentration of 25 μM should be used which is within the 
physiological range (Wiesenfeld et al., 2001). 
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Figure 1. Comparing BSA and EtOH as DHA vehicle in vitro. Balb/c AM supplemented 
with vehicle (EtOH or BSA) or DHA (25 μM) for 48 hours and exposed to particle 
(MWCNT or SiO2, 50 μg/mL) for 24 hours. (A) Cell viability comparing treatment groups. 
(B) IL-1β release from those same cells. Data presented as mean ± SEM, n=3. *P<0.05, 
**P<0.01, ***P<0.001, ****P<0.0001 compared to baseline, + compared to different 
treatments within the same exposure group. Some analyses were done with log-
transformed data. AMs, Balb/c alveolar macrophages; EtOH, ethanol; BSA, bovine serum 
albumin; DHA, docosahexaenoic acid; MWCNT, multi-walled carbon nanotube; SiO2, 
crystalline silica. 
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In order to assess the cytotoxic effects of particles on each polarized macrophage 
phenotype, AM were treated with DHA for 48 hours, exposed to particles for 24-hours and 
lactate dehydrogenase (LDH) release was evaluated to determine cell death. Media-only 
controls were included throughout the in vitro studies as a confirmation that EtOH was not 
having a toxic effect on AM and EtOH controls were included to demonstrate that the 
reactions were caused by DHA specifically and not due to EtOH exposure. Results 
indicated that there was a trending decrease of cell death for unpolarized AM (M0) treated 
with DHA and exposed to SiO2 when compared to the media-only control (Figure 2A); 
however, there was no difference for MWCNT with DHA treatment. DHA didn’t appear 
to have a cytotoxic effect compared to the media-only control in the M1 phenotype for 
either particle compared to the media-only controls (Figure 2B); however, the M2 subsets 
responded differently. In M2a AM, there was a trending increase in cell death when DHA 
was present and exposed to SiO2, but there was no difference with MWCNT exposure 
compared to media-only controls (Figure 2C). For M2b, there were significant decreases 
in cell death with DHA treatment regardless of particle exposure (Figure 2D). There was 
no difference in cell death when exposed to MWCNT, but there was a trending decrease in 
cell death when exposed to SiO2 with DHA treatment for M2c (Figure 2E). The beneficial 
effects of DHA treatment with particle exposure appeared to be M2b>M2c>M1>M2a. The 
cytotoxicity assessment supported the hypothesis that cytotoxic responses induced by 
particles with DHA treatment differ between the macrophage phenotypes. 
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Figure 2. Lactate dehydrogenase (LDH) analysis of macrophage phenotypes in vitro. 
Balb/c AM were either (A) not polarized; M0, or polarized into (B) M1, (C) M2a, (D) M2b, 
or (E) M2c macrophage phenotypes for 24 hours, supplemented with vehicle (100% EtOH) 
or DHA for 48 hours, and exposed to particles (MWCNT or SiO2) and LPS priming for 24 
hours. LDH levels were assessed in AM supernatant. Data presented as mean ± SEM, n=3. 
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to no particle control, + compared 
to different treatments within the same exposure group. Analyses were done with log-
transformed data. 
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3.3.2 Effects of DHA on IL-1β release in vitro 
Particles are engulfed in a phagolysosome after AM phagocytosis that can result in particle-
induced phagolysosomal membrane permeabilization (LMP) which leads to the release of 
IL-1β and cytotoxicity. Little is known about IL-1β release between the macrophage 
phenotypes or the ability of DHA to block this release in regard to particle exposures. 
Furthermore, this information can be used to help determine if the particle cytotoxicity, as 
shown above, is linked to LMP and if the macrophage phenotypes process particles 
differently. Therefore, IL-1β release after 24-hours of particle exposure using the same AM 
supernatant of the cells described above in the cytotoxicity assay was measured. As 
expected, there was no IL-1β release from any of the AM phenotypes for the no particle 
media-only groups (Figure 3). However, exposure to MWCNT and SiO2 without DHA 
treatment induced varied levels of IL-1β release between the phenotypes which ranked 
M2c>M2b>M2a>M1 (Figure 3). 
Upon treatment with DHA, M0 AM had a significant decrease of IL-1β release 
when exposed to MWCNT and a decreasing trend when exposed to SiO2 when compared 
to media-only controls (Figure 3A). In M1 AM, there was a trending decrease in IL-1β 
release when exposed to MWCNT and treated with DHA compared to the media-only 
control; however, there was no change in IL-1β levels compared to media-only control 
when exposed to SiO2 (Figure 3B). There appeared to be a slight increase of IL-1β release 
compared to media-only control when treated with DHA and exposed to SiO2, but no 
difference with MWCNT for M2a AM (Figure 3C). Both M2b (Figure 3D) and M2c 
(Figure 3E) AM had a significant or trending decrease in IL-1β release when treated with 
DHA and exposed to either particle compared to media-only controls. The M2c results  
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Figure 3. IL-1β release of macrophage phenotypes in vitro. Balb/c AM were either (A) not 
polarized; M0, or polarized into (B) M1, (C) M2a, (D) M2b, or (E) M2c macrophage 
phenotypes for 24 hours, supplemented with vehicle (100% EtOH) or DHA for 48 hours, 
and exposed to particles (MWCNT or SiO2) and LPS priming for 24 hours. IL-1β  levels 
were assessed in AM supernatant. Data presented as mean ± SEM, n=3. *P<0.05, **P<0.01, 
***P<0.001, ****P<0.0001 compared to no particle control, + compared to different 
treatments within the same exposure group. Analyses were done with log-transformed data. 
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positively correlated to the decreased cell death with DHA treatment as shown earlier. The 
ability of DHA to significantly decrease IL-1β levels upon particle exposure ranked as 
M2c>M2b>M1>M2a. These results indicated that the macrophage phenotypes are 
responding differently to particles. The prophylactic treatment of DHA with two different 
types of particle exposures had a positive effect on cell viability and IL-1β release which 
supports the hypothesis that DHA is protective over particle-induced inflammatory 
responses which varies between each macrophage phenotype. In addition, these novel 
findings point out that there are significant differences between the various macrophage 
phenotypes which indicates that they should not be grouped together for interpretation; 
especially the M2c subset in this particular model.  
 
3.3.3 Effect of DHA on particle uptake and LMP in vitro 
There were differences between the macrophage phenotypes upon DHA treatment in 
regard to cell viability which could be attributed to the differences in IL-1β release. IL-1β 
release is linked to LMP which can occur after AM phagocytose particles. Therefore, these 
differences between the responses of the macrophage phenotypes could be attributed to 
different rates of particle phagocytosis which has not been previously investigated. Particle 
uptake by AM was measured with and without DHA treatment and 4-hours of particle 
exposure by assessing changes in side scatter. The M0 AM were the most efficient in 
particle uptake; especially with SiO2, and the M1 AM were the least (Figure 4 A,B). This 
could explain the relative particle toxicity and lowest IL-1β release in the M1 population. 
There was a significant increase in particle uptake by M0 AM with DHA treatment 
regardless of particle exposure when compared to media-only controls  
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Figure 4. Particle uptake of macrophage phenotypes in vitro. Balb/c AM were either (A) 
not polarized; M0, or polarized into (B) M1, (C) M2a, (D) M2b, or (E) M2c macrophage 
phenotypes for 24 hours, supplemented with vehicle (100% EtOH) or DHA for 24 hours, 
and exposed to particles (MWCNT or SiO2) and LPS priming for 4 hours. Particle uptake 
was determined by side scatter via flow cytometry. Data presented as mean ± SEM, n=3. 
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to no particle control, + compared 
to different treatments within the same exposure group. Analyses were done with log-
transformed data. 
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(Figure 4A). There was a significant decrease in particle uptake with DHA treatment for 
M1 AM when exposed to SiO2, but no change when exposed to MWCNT (Figure 4B). 
M2a AM (Figure 4C) were similar to M0 AM where they had a significant increase of 
particle uptake with DHA treatment regardless of particle exposure. M2b (Figure 4D) and 
M2c (Figure 4E) AM were similar where they had opposite particle reactions when treated 
with DHA: there was a decrease of particle uptake with MWCNT and a significant increase 
with SiO2 for both phenotypes compared to media-only controls. 
Once the particles are phagocytosed by AM they are enclosed in a phagolysosome 
where foreign material is intended to be degraded in order to maintain homeostasis. 
However, non-degradable particles can cause LMP which leads to NLRP3 inflammasome 
formation and activation of the inflammatory pathway cascade. Since the macrophage 
phenotypes showed differences in particle uptake, alterations in the stability of the 
phagolysosomal membrane was assessed after 4-hours of particle exposure. LMP was 
determined by β-N-acetylglucosaminidase (NAG) activity; a lysosomal-specific enzyme, 
in the cytosolic fraction of AM polarized into the various phenotypes. Results showed that 
MWCNT exposure caused a significant particle-induced increase of LMP only in the M2c 
AM which is consistent with this phenotype’s largest release of IL-1β. However, upon 
DHA treatment both the M2c (Figure 5E) and M0 (Figure 5A) AM had trending decreases 
in NAG release for MWCNT exposures and a significant decrease in NAG release with 
DHA treatment for SiO2 exposures when compared to media-only controls. This indicates 
less LMP which correlates to increased phagolysosomal membrane stability. In contrast, 
M1 (Figure 5B) and M2a (Figure 5C) AM had an increase in NAG release upon DHA 
treatment compared to media-only controls for both particle  
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Figure 5. LMP analysis of macrophage phenotypes in vitro. Balb/c AM were either (A) 
not polarized; M0, or polarized into (B) M1, (C) M2a, (D) M2b, or (E) M2c macrophage 
phenotypes for 24 hours, supplemented with vehicle (100% EtOH) or DHA for 24 hours, 
and exposed to particles (MWCNT or SiO2) and LPS priming for 4 hours. NAG release 
was assessed in the AM cytosolic fraction and normalized to LDH levels. Data presented 
as mean ± SEM, n=3. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to no particle 
control, + compared to different treatments within the same exposure group. Some analyses 
were done with log-transformed data. 
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exposures; indicating an increase in LMP which correlates to a decrease in phagolysosomal 
membrane stability. The M2b AM remained unchanged by DHA treatment compared to 
the media-only control for either particle (Figure 5D). These results demonstrate that DHA 
stabilized the phagolysosomal membrane of the M0 and M2c AM after particle exposure. 
The benefits of DHA treatment for particle-induced LMP ranked M2c>M2b>M2a>M1 for 
the AM phenotypes. Taken together for the in vitro studies, DHA effected how 
macrophages uptake particles and altered the phagolysosomal membrane; both which 
differ among the macrophage phenotypes. In particular, upon DHA treatment the M2c 
phenotype stabilized the phagolysosomal membrane and decreased cytotoxicity regardless 
of increased particle uptake. As opposed to the M2a phenotype where DHA also increased 
particle uptake, but resulted in increased LMP and increased cytotoxicity. This supports 
the hypothesis that particle-induced inflammatory responses were not uniform across the 
different macrophage phenotypes; however, DHA did not always downregulate the 
inflammatory responses. 
 
3.3.4 Effect of DHA on lung injury and inflammation in vivo 
The in vitro studies demonstrated that DHA altered the response of AM which was 
dependent upon macrophage phenotype. In order to determine whether the in vitro 
outcomes translated to in vivo effects, mice were put on a prophylactic 1% DHA diet and 
instilled with an acute particle exposure. The overall study design is depicted in Figure 6. 
Briefly, Balb/c mice were put on either a control or 1% DHA diet for three weeks. Twenty-
four hours prior to evaluation, the mice were oropharyngeal instilled with either dispersion 
media-only vehicle (DM; 50 µl/mouse), MWCNT (50 µg/mouse), or SiO2  
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Figure 6. Experimental design of prophylactic acute model. Balb/c mice; 6-8 weeks old, 
were put on a control or 1% DHA diet for 3 weeks. 24 hours prior to evaluation, the mice 
were oropharyngeal instilled with DM-only, MWCNT, or SiO2. DM; dispersion media, 
MWCNT; multi-walled carbon nanotube, SiO2; crystalline silica. 
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Table 2. Fatty acid composition of red blood cells in prophylactic acute model. Data 
presented in a percentage as mean ± SEM, n=4. 
 
 
 
 
 
 
 
P24h (OmegaQuant): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Groups 
Control Diet 1% DHA Diet 
DM MWCNT SiO2 DM MWCNT SiO2 
Fatty Acid % of fatty acid in RBC 
14:0 0.15 ± 8.13E-05 0.15 ± 9.91E-05 0.13 ± 3.59E-05 0.24 ± 3.85E-05 0.21 ± 1.17E-04 0.23 ± 5.00E-05 
16:0 27.61 ± 4.78E-03 27.40 ± 5.62E-03 27.70 ± 2.25E-03 31.35 ± 3.94E-03 30.12 ± 2.01E-03 31.17 ± 4.81E-03 
16:1 (ω-7) trans 0.06 ± 7.12E-05 0.06 ± 4.17E-05 0.07 ± 6.38E-05 0.05 ± 1.01E-04 0.05 ± 5.19E-05 0.08 ± 1.45E-04 
16:1 (ω-7) 0.35 ± 5.49E-04 0.35 ± 4.08E-04 0.36 ± 5.19E-04 0.44 ± 4.13E-04 0.36 ± 2.89E-04 0.41 ± 1.57E-04 
18:0 12.91 ± 4.02E-03 13.72 ± 4.49E-03 13.03 ± 4.02E-03 11.11 ± 4.39E-03 11.97 ± 3.24E-03 11.45 ± 4.78E-03 
18:1 trans 0.18 ± 1.40E-04 0.12 ± 3.07E-05 0.17 ± 2.58E-04 0.13 ± 6.72E-05 0.13 ± 1.24E-04 0.14 ± 1.78E-04 
18:1 (ω-9) 19.02 ± 3.31E-03 18.65 ± 3.02E-03 18.28 ± 2.66E-03 16.87 ± 3.01E-03 16.59 ± 7.36E-04 16.61 ± 9.92E-04 
18:2 (ω-6) trans 0.19 ± 2.68E-04 0.15 ± 1.18E-04 0.15 ± 7.46E-05 0.12 ± 8.25E-05 0.14 ± 3.09E-04 0.15 ± 2.52E-04 
18:2 (ω-6) 8.25 ± 4.37E-03 7.97 ± 9.14E-04 7.78 ± 4.88E-03 9.33 ± 7.95E-03 9.67 ± 4.57E-03 8.74 ± 1.66E-03 
18:3 (ω-6) 0.07 ± 3.75E-05 0.07 ± 5.92E-05 0.06 ± 2.99E-05 0.03 ± 4.91E-05 0.04 ± 1.97E-05 0.05 ± 6.21E-05 
18:3 (ω-3) 0.07 ± 8.57E-05 0.07 ± 7.14E-05 0.06 ± 4.36E-05 0.07 ± 7.53E-05 0.07 ± 5.54E-05 0.08 ± 7.10E-05 
20:0 0.18 ± 3.28E-04 0.14 ± 2.67E-04 0.16 ± 2.19E-04 0.17 ± 4.01E-04 0.14 ± 3.75E-04 0.18 ± 3.70E-04 
20:1 (ω-9) 0.53 ± 2.00E-04 0.47 ± 3.28E-04 0.47 ± 2.23E-04 0.33 ± 1.34E-04 0.32 ± 1.92E-04 0.36 ± 3.16E-04 
20:2 (ω-6) 0.22 ± 1.14E-04 0.19 ± 1.11E-04 0.20 ± 6.24E-05 0.16 ± 6.73E-05 0.17 ± 4.31E-05 0.16 ± 9.33E-05 
20:3 (ω-6) 1.24 ± 7.94E-04 1.07 ± 7.84E-04 1.18 ± 7.71E-04 0.97 ± 6.77E-04 1.12 ± 1.29E-03 1.00 ± 1.13E-03 
20:4 (ω-6) 19.11 ± 5.52E-03 19.49 ± 5.84E-03 19.52 ± 5.02E-03 7.83 ± 5.41E-03 8.52 ± 6.97E-03 8.24 ± 7.35E-04 
20:5 (ω-3) 0.06 ± 9.72E-05 0.05 ± 3.83E-05 0.06 ± 6.77E-05 1.69 ± 2.37E-03 1.64 ± 9.74E-04 1.63 ± 1.28E-03 
22:0 0.14 ± 7.83E-05 0.13 ± 7.91E-05 0.14 ± 8.77E-05 0.16 ± 1.25E-04 0.16 ± 1.12E-04 0.16 ± 1.40E-04 
22:4 (ω-6) 2.38 ± 9.58E-04 2.18 ± 2.76E-04 2.29 ± 8.14E-04 0.80 ± 6.29E-04 0.80 ± 4.56E-04 0.90 ± 5.53E-04 
22:5 (ω-6) 2.34 ± 1.24E-03 2.32 ± 8.03E-04 2.56 ± 6.78E-04 0.43 ± 2.19E-04 0.42 ± 6.70E-04 0.46 ± 5.56E-04 
22:5 (ω-3) 0.30 ± 2.98E-04 0.23 ± 3.39E-04 0.27 ± 3.17E-04 0.55 ± 2.58E-04 0.51 ± 1.48E-04 0.59 ± 1.56E-04 
22:6 (ω-3) 4.26 ± 1.10E-03 4.67 ± 1.01E-03 4.98 ± 2.55E-03 16.77 ± 6.14E-03 16.42 ± 3.52E-03 16.82 ± 3.20E-03 
24:0 0.18 ± 7.74E-05 0.17 ± 9.00E-05 0.19 ± 2.05E-04 0.21 ± 1.67E-04 0.22 ± 1.20E-04 0.22 ± 1.75E-04 
24:1 (ω-9) 0.20 ± 1.81E-04 0.18 ± 1.59E-04 0.20 ± 1.33E-04 0.19 ± 5.82E-05 0.21 ± 1.20E-04 0.19 ± 1.29E-04 
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Figure 7. Fatty acid analysis within red blood cells in prophylactic acute model. Balb/c 
mice were put on a control or 1% DHA diet for three weeks and 24 hours prior to evaluation 
the mice were instilled with either DM, MWCNT, or SiO2. Percentage of DHA content 
between control and 1% DHA diet. Data presented as mean ± SEM, n=4. *P<0.05 compared 
to DM, ++++P<0.0001 compared to different treatments within the same exposure group. 
Analyses were done with log-transformed data. 
 
 
 
 
 
 
 
 
 39 
(1 mg/mouse). Twenty-four hours after instillation, whole lung lavages were performed in 
order to assess inflammatory responses and collect lung immune cells. Confirmation of 
fatty acid composition within red blood cells was sent for analysis (Table 2) which 
confirmed an increase in DHA content within the DHA-fed mice compared to the control 
diet (Figure 7). 
Lung injury and inflammation were assessed by analyzing LDH levels (indicative 
of overall pulmonary cellular damage), protein concentrations (a marker for epithelial cell 
damage), and various inflammatory and pro-resolving cytokines within the lung lavage 
fluid (LLF). Results showed that DHA-fed mice exposed to DM-only had a trending 
decrease in both LDH levels and protein concentration within the LLF, suggesting basal 
level protection (Figure 8 A,B). However, when mice were exposed to either particle there 
was an increase in lung damage as indicated by increased LDH and protein in the LLF of 
mice on the DHA diet (Figure 8 A,B). There were also consistent increases in inflammatory 
cytokines within the LLF; such as IFNγ, IL-1β, TNFα, and IL-33 (Figure 8C), with mice 
exposed to either particle while on the DHA diet. IL-6 levels had a trending increase in 
mice exposed to MWCNT on the DHA diet; however, IL-6 levels were decreased in SiO2-
exposed mice on the DHA diet when compared to control mice (Figure 8C). There were 
some differences between the control and DHA diet-fed mice for the exposure groups for 
IL-13 levels; however, both IL-13 and IL-10 levels were extremely low overall. These 
results indicate increased lung damage of mice on the DHA diet with acute particle 
exposure compared to the control diet which may suggest that the increased pulmonary 
injury and inflammation may be due to increased recruitment of other inflammatory cells 
at this timepoint. 
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Figure 8. Assessment of lung damage and cytokine analysis within the LLF for 
prophylactic acute model. Balb/c mice were put on a control or 1% DHA diet for three 
weeks and 24 hours prior to evaluation the mice were instilled with either DM, MWCNT, 
or SiO2. (A) LDH release and (B) protein concentration were assessed for lung damage. 
(C) Inflammatory cytokines; IFN-γ, IL-1β, TNFα, IL-33, pro-resolving cytokines; IL-10, 
and IL-13, and IL-6 were analyzed in the LLF. Data presented as mean ± SEM, n=5-6. 
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to DM, + compared to different 
diet within the same exposure group. Analyses were done with log-transformed data. 
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Figure 9. Analysis of cell types within LLF for prophylactic acute model. Balb/c mice were 
put on a control or 1% DHA diet for 3 weeks and 24-hours prior to evaluation the mice 
were instilled with either DM, MWCNT, or SiO2. Percentage of cell types were assessed 
via cytospins of cell differentials. Data presented as mean ± SEM, n=5-6. *P<0.05, 
**P<0.01, ***P<0.001, ****P<0.0001 comparing exposures within same diet, + comparing 
the same exposure between diets. Analyses were done with log-transformed data. 
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3.3.5 DHA’s effect on pulmonary cells in vivo 
Since there was an increase in inflammatory mediators within the LLF, the cell differentials 
were determined (Figure 9). Mice instilled with DM-only had predominantly AM 
regardless of diet. Both particles also had AM present; however, they induced granulocyte 
recruitment that were dominated by neutrophils with a few eosinophils. There were no 
differences between the total number of cells when comparing the control diet and DHA 
diet (data not shown). These results confirmed an increase in inflammatory signaling within 
the DHA-fed mice which could indicate that mice on the DHA diet have an enhanced 
response to particle exposure compared to mice on the control diet. 
  The analysis of AM and the impacts due to DHA are crucial to understanding DHA 
as a potential treatment for particle-induced inflammation since macrophages are key 
players in phagocytosing foreign materials. The in vitro studies indicated that DHA could 
decrease particle-induced IL-1β release from M0 AM. Therefore, AM were isolated from 
the LLF and cultured ex vivo in order to assess IL-1β release (Figure 10A). Mice instilled 
with DM-only while on the DHA diet had a significant decrease in IL-1β release suggesting 
that DHA decreased basal AM inflammatory potential. When mice were instilled with 
MWCNT while on the DHA diet there was a significant increase of IL-1β release from AM 
compared to mice on the control diet. However, mice on the DHA diet and instilled with 
SiO2 showed a trending decrease in IL-1β release. Since IL-1β is due to the activation of 
the NLRP3 inflammasome; which can be triggered by LMP, cathepsin release (a product 
of LMP) was measured within the LLF as an in vivo indicator of LMP. There was a 
significant increase of total cathepsin release within the LLF of mice exposed to either 
particle compared to the DM-only mice which was further  
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Figure 10. Assessment of LMP for prophylactic acute model. Balb/c mice were put on a 
control or 1% DHA diet for 3 weeks and 24-hours prior to evaluation the mice were 
instilled with either DM, MWCNT, or SiO2. LMP was assessed through detection of (A) 
IL-1β release directly from AM ex vivo, (B) total cathepsin release within the LLF, and (C) 
cathepsin B release within the LLF. Data presented as mean ± SEM, n=5-6. *P<0.05, 
**P<0.01, ****P<0.0001 compared to DM, + compared to different diet within the same 
exposure group. Analyses were done with log-transformed data. CTS, cathepsin. 
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increased in mice on the DHA diet regardless of particle exposure (Figure 10B). There 
were also trending increases of cathepsin B levels, which has been linked to LMP 
specifically, in the LLF for mice on the DHA diet and instilled with either particle (Figure 
10C). These results demonstrate an increase in inflammatory cascades with mice on the 
DHA diet which is in contrast to the in vitro results as well as the hypothesis that DHA 
downregulates particle-induced inflammatory responses. 
 
3.3.6 Alteration of macrophage phenotype by DHA in vivo 
The prophylactic treatment of DHA with an acute exposure to MWCNT and SiO2 exhibited 
varying effects on AM from Balb/c mice. The in vitro analysis demonstrated that the impact 
of DHA on an acute particle exposure differs between the macrophage phenotypes. In order 
to better understand why the in vivo outcomes did not follow the predicted outcomes from 
the in vitro studies, changes in macrophage phenotype were examined within lung and 
spleen tissues of these mice. Recent studies in our laboratory have shown significant 
trafficking of MWCNT into the spleen and changes in immune cell populations; therefore, 
spleen tissue was included in this portion of the study. qPCR was performed in order to 
examine relative gene expression levels to assess shifts in macrophage phenotype 
depending on particle exposure and DHA treatment. As seen in the lung tissue, the 
expression levels of most genes were downregulated when analyzing the particle-only 
effect (Figure 11A); however, there was a shift in macrophage phenotype when assessing 
the DHA diet effect (Figure 11B). There was a dominant phenotype shift towards M2c with 
mice exposed to MWCNT and on the 1% DHA diet which is indicative of pro-resolving 
tissue repair and matrix deposition, but a trending  
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Figure 11. Impact of particle exposure and DHA treatment on macrophage phenotype for 
prophylactic acute model. Balb/c mice were put on a control or 1% DHA diet for 3 weeks 
and 24-hours prior to evaluation the mice were instilled with either DM, MWCNT, or SiO2. 
Relative gene expression of control diet MWCNT or SiO2 mice were normalized to control 
diet DM mice for assessment of particle effect in (A) lung and (C) spleen tissues. Relative 
gene expression of 1% DHA diet mice were normalized to corresponding control diet mice 
for assessment of diet effect in (B) lung and (D) spleen tissues. Each bar within the heat 
maps consist of 5-6 mice for lung tissue and 4 mice for spleen tissue. 
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upregulation of M2b markers. When mice were exposed to SiO2 while on the 1% DHA 
diet there was a dominant phenotype shift towards M1 and M2b which have overlapping 
roles indicative of increased inflammatory signaling; however, a trending upregulation of 
the M2c phenotype. This indicated that DHA treatment may have enhanced responses in 
the MWCNT-exposed mice towards the pro-resolving phenotype compared to that in the 
SiO2-exposed mice. 
Particles were not anticipated to be present in the spleen at this early timepoint; 
however it has been shown that particle exposure can have systemic effects (X.-Y. Li et 
al., 2017; Pollard, 2016). The results within the spleen tissue suggest that there was a 
trending upregulation in M2c gene expression with mice exposed to the MWCNT, but no 
macrophage phenotype shift for mice exposed to SiO2 when assessing a particle-only effect 
(Figure 11C). Upon DHA treatment in the spleen tissue, DM-only mice had trending 
upregulated M2a gene expression and a trending upregulation of M2c gene expression 
which suggested priming of a M2 tissue repair response within the spleen at this time 
(Figure 11D). When mice were exposed to MWCNT on the 1% DHA diet there was an 
overall downregulation in gene expression in the spleen. However, there was a trending 
upregulation of the M2a phenotype for mice on the 1% DHA diet when exposed to SiO2 
(Figure 11D). An upregulation of expression for a few other genes occurred in SiO2-
exposed mice while on the 1% DHA diet; however, not enough to be indicative of a 
dominant macrophage phenotype shift. These results suggest that mice on the 1% DHA 
prophylactic diet altered macrophage phenotype responses within both lung and spleen 
tissues which differed between particle exposure type. DHA treatment pushed macrophage 
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responses towards an M2c phenotype which supported the in vitro findings that DHA 
impacts the M2c phenotype more than the other phenotypes. 
 
3.3.7 Effect of DHA on lung histopathology in vivo 
DHA increased inflammatory signaling cascades within the LLF; however, gene 
expression of macrophage phenotypes within tissues after DHA treatment had upregulation 
of pro-resolving phenotypes. Therefore, investigation of DHA’s impact on particle-
induced lung pathology was assessed. Lung tissue sections from these mice were stained 
with Masson’s trichrome and scored for histological analysis. The degree of lung 
inflammation was scored on a 5-point scale system (0, 1, 2, 3, 4) with 0 being no effect and 
4 indicating extreme lung inflammation. As seen in Figure 12A, there was a consistent 
trending increase in lung inflammation with mice exposed to either particle while on the 
DHA diet compared to the control diet-fed mice. Airway thickness was also measured in 
similar sized airways. Upon DHA treatment, there was a trending decrease of airway 
thickness for MWCNT-exposed mice when compared to the control diet-fed mice (Figure 
12B). SiO2-exposed mice had a significant increase in airway thickness for mice on the 
DHA diet compared to the control diet. Figure 12C shows representative photomicrographs 
of airways and surrounding tissues. These results indicated that DHA did not protect the 
lung pathology when exposed to either inflammatory particle after 24-hours. 
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Figure 12. Histopathology analysis of lung tissue for prophylactic acute model. Balb/c 
mice were put on a control or 1% DHA diet for 3 weeks and 24-hours prior to evaluation 
the mice were instilled with either DM, MWCNT, or SiO2. (A) Pathology was scored 
blinded by two observers. Data presented as median ± SEM, n=3. (B) Airway thickness 
was measured blinded. Data presented as mean ± SEM, n=3. (C) Representative images 
(10x) of Masson’s trichrome-stained lung airway sections. *P<0.05, **P<0.01 compared to 
DM, + compared to different diet within the same exposure group. Arrows indicate particle 
encapsulation, blue staining indicates collagen deposition. 
 
 
 
 49 
3.4 Discussion 
It has been reported that DHA has anti-inflammatory properties; however, its impacts on 
particle-induced inflammation, especially in regard to comprehensive evaluations of 
murine strains and macrophage phenotype, remain to be determined. When macrophages 
take up particles that can cause LMP; such as MWCNT and SiO2, this can initiate 
inflammation, which macrophages can either aid or suppress through phenotype shifts. It 
has yet to be determined if particle-induced inflammation can be treated by DHA due to 
impacting macrophage phenotype and/or altering LMP. The current in vitro studies showed 
that particles had differential effects on individual macrophage phenotypes and DHA 
treatment could downregulate the inflammatory cascade in some but not all phenotypes.  
The current results provided new information on the response of individual 
macrophage phenotypes to two toxic/inflammatory particles as well as the effects of DHA 
on the response of the individual macrophage phenotypes to the two particles. While the 
main focus of the studies was to explore potential anti-inflammatory mechanisms of DHA 
on macrophages and macrophage phenotypes, the study also clearly demonstrated 
variability in responses of the phenotypes to particles alone without DHA treatment that 
should help better understand outcomes in vivo. For example, differences in MWCNT and 
SiO2 toxicity were most apparent in M2c macrophages and least in M1 macrophages. M2c 
macrophages also had the greatest particle-induced IL-1β release. The M1 macrophages 
had the lowest particle uptake, suggesting that high levels of M1 macrophages in vivo could 
result in lower particle uptake. The pattern of LMP followed roughly the same order since 
both MWCNT and SiO2-induced LMP was greatest in M2c macrophages and lowest in M1 
macrophages, consistent with the relative order of IL-1β release. Therefore; particle uptake, 
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LMP and IL-1β release were relatively consistent. It should be noted that these studies were 
conducted using primary alveolar macrophages isolated from Balb/c mice using previously 
published techniques to polarize macrophages, as described in Methods. Whether the same 
pattern would occur in other strains of mice remains to be determined. 
The in vitro treatment of macrophages with DHA indicated that DHA was able to 
slightly decrease cellular cytotoxicity caused by particles within each macrophage 
phenotype, resulting in less IL-1β release. DHA also altered particle uptake depending on 
macrophage phenotype as well as the type of the particle which tended to increase for SiO2 
uptake upon DHA treatment. These results were consistent with the ability of DHA to 
decrease LMP caused by both particles which mechanistically explains the decreased IL-
1β release. Even though the highest levels of toxicity, IL-1β release, and LMP caused by 
particles were in the M2c phenotype, this same phenotype had the most protection caused 
by DHA treatment. This indicated that DHA has the capability to decrease the most robust 
inflammatory response caused by particles. 
The current studies showed differences between the MWCNT- and SiO2-exposed 
models both in vitro and in vivo upon DHA treatment which might be attributed to their 
differences in particle size, charge, morphology, or composition. MWCNT are 
hydrophobic rolled graphene sheets with a greater surface area per mass that are 1–100 nm 
in at least one dimension in size (Saifuddin et al., 2013). In contrast, the surface of SiO2 is 
hydrophilic and commonly found in nature as quartz which can be the size of <10 μm 
(Dyachenko et al., 2004; Pollard, 2016). Whether some of the differences that were 
observed in the current studies are due to particle size, composition, or surface 
characteristics remains to be determined. Importantly, the current results show that DHA 
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treatment does not benefit all particle-exposure models which could also vary between cell 
type and mouse strain. 
The ability of AM to phagocytose these particles affected their LMP in vitro which 
differed between the various phenotypes, indicating that the phagolysosomal membrane 
within each of the phenotypes was altered. One possible explanation could be differences 
in scavenger receptors between the various macrophage phenotypes which in turn affects 
how they respond to phagocytosing particles. It has been shown that there is an increase of 
CD36 in M1 macrophages and an increase in both SR-A1 and CD163 in M2a macrophages 
(Canton et al., 2013). One study reported that STAT3 induces CD36 expression in a chronic 
lymphocytic leukemia model and that fatty acid uptake is facilitated by STAT3-mediated 
expression of CD36 (Rozovski et al., 2018). In a gastric cancer model, STAT3 was an 
important regulator of CD163 (Cheng et al., 2017). In the current in vitro studies, we 
observed an increase in particle uptake of MWCNT when exposed to DHA in M2a and of 
SiO2 in M2a, M2b, and M2c which could suggest that the other M2 subsets also have an 
increase of CD163 which could be altered by STAT3. However, there may be differences 
in either STAT3 or CD163 expression in the M2b and M2c subsets because there was a 
decrease in MWCNT uptake when exposed to DHA. While scavenger receptors are known 
to be responsible for the uptake of SiO2 (Hamilton et al., 2006), scavenger receptors for 
MWCNT exposure are less well-described. There is also the possibility that fatty acid 
incorporation into the membranes occurs differently between the macrophage phenotypes 
The type of particle exposure could potentially alter these expressions as well depending 
on the differences in physiochemical properties as indicated above. For the most part, DHA 
treatment had a beneficial effect on AM in vitro after a 24-hour particle exposure, 
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specifically in the M2c phenotype. However; the in vivo 24-hour particle exposure study 
showed a different outcome. 
The current in vivo study where mice exposed to particles for 24-hours while on a 
prophylactic 1% DHA diet caused an increase in lung damage and inflammatory cytokines 
for mice on the DHA diet. There is a constant cross-talk between macrophages and 
epithelial cells within the lungs. One study reported that DHA-fed mice had a significant 
increase of amphiregulin (AREG); which promotes the normal growth of epithelial cells 
by interacting with epidermal growth factor receptor (EGFR), when exposed to dust extract 
in lung tissue compared to the control diets (Nordgren et al., 2018). When DHA-fed mice 
were exposed to particles in the current study there was an increase in neutrophils, 
increased protein concentration, and increased IL-33 levels in the LLF which indicates that 
DHA could be affecting epithelial cells within the lung tissue at this particular timepoint. 
Efferocytosis (of neutrophils) by AM could have occurred, initiating a signaling cascade 
with secretion of TGFβ and prostaglandin E2 (PGE2) (Allard et al., 2018). A characteristic 
of the M2c phenotype is increased TGFβ and the current in vivo study had increased M2c 
gene expression within the lung and spleen tissues upon DHA treatment. One study 
reported that when airway epithelial cells were exposed to LPS, COX2 was upregulated 
resulting in an increase of PGE2. PGE2 can bind to receptors on AM leading to increased 
suppressor of cytokine signaling (SOCS)-3 proteins where AM secrete SOCS3 and 
epithelial cells uptake SOCS3 in turn inhibiting STAT3 (Speth et al., 2016). It has been 
shown that the IL-6/STAT3 pathway is inhibited in M1 macrophages which was confirmed 
by showing that M0 macrophages turned into M1 macrophages with the inhibition of IL-
6/STAT3. However; IL-6/STAT3 is activated in M2a macrophages (Yin et al., 2018). IL-
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6 levels within the LLF of the current in vivo study had opposite effects upon DHA 
treatment between MWCNT- and SiO2-exposed mice. In the current in vitro studies, we 
observed distinct differences between the M1 and M2 subset phenotypes; including 
cytotoxicity, IL-1β release, particle uptake, and LMP. These differences in phenotype 
could be linked to the alterations of IL-6/STAT3. This pathway should be researched 
further between the different macrophage phenotypes upon particle exposure. 
DHA has been reported to inhibit STAT3 in a PPARγ/SOCS3-dependent manner 
when exposed to Helicobacter pylori infection in a human gastric cancer AGS cell model 
(Ji et al., 2016). The current in vivo study had increased inflammatory markers when mice 
were fed the DHA diet which could mean that DHA is inhibiting STAT3 which could 
increase a M1 dominant phenotype at this particular timepoint for cell signaling. This might 
indicate that DHA treatment caused an increased inflammatory response in a shorter period 
of time in order to quickly resolve damage caused by particles. In a different gastric cancer 
tumor model, M2 macrophages positively correlated with IL-6 expression and when 
STAT3 was knocked down there was a decrease in IL-10 and TGFβ cytokines; which are 
linked to overall M2 and specifically M2c phenotypes, respectively (Fu et al., 2017). The 
current in vivo study showed that DHA increased IL-6 levels within the LLF of DM-only 
and MWCNT-exposed mice and increased M2c gene expression in lung tissue. DHA 
appears to be impacting the M2c phenotype more than the other subsets as indicated both 
in vitro and in vivo throughout these studies which further supports the notion that 
additional phenotypes, other than M1 and M2a, should be included in future studies. The 
M2c phenotype seems to process particle exposures differently. STAT3 has also been 
found to directly modulate lysosomal membrane components to induce lysosomal 
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leakiness and upregulate cathepsin B, which resulted in cell death within mammary gland 
epithelial cells (Lloyd-Lewis et al., 2018). The current in vivo study showed an increase in 
both total cathepsin and cathepsin B release in the LLF of 1% DHA-fed mice when exposed 
to particles. This also correlated to the current in vitro studies where there was an increase 
in LMP when treated with DHA and exposed to particles within M1 and M2a phenotypes 
which means this could be linked to alterations of STAT3 between the macrophage 
phenotypes. 
In summary, there is still much to be determined when assessing the differences 
between macrophage phenotypes when exposed to various particles. The phenotypes do 
not act the same when exposed to particles as shown here by assessing cytotoxicity, particle 
uptake, various inflammatory mediators, and LMP in vitro. DHA aids in suppressing 
inflammation and increasing particle uptake; however, it varies between phenotypes. After 
24-hours of particle exposure in vivo, DHA had a rapid response to particle infiltration 
within the body to begin signaling for inflammatory mediators compared to the control 
diet. The current in vivo study indicated that further research needs to be done in order to 
assess the impacts of DHA on epithelial cells for this inflammatory signaling cascade; 
however, DHA did alter macrophage phenotype gene expression patterns within various 
tissues suggesting that it is preparing the body to shift to a tissue-resolving phase. The goals 
of the in vitro studies were to assess the different macrophage phenotype responses to 
particle exposure and the impacts of DHA treatment. However, the current in vivo study 
indicated a crosstalk among different cells which the in vitro studies could not have 
anticipated which demonstrated that in vitro studies can not always be used to translate 
directly into in vivo outcomes. Future research needs to be done to assess the crosstalk 
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between epithelial cells and the different macrophage phenotypes with particle-induced 
inflammation in vitro. Semi-acute and chronic in vivo studies need to be completed in order 
to assess if DHA can resolve the inflammation quicker when compared to the control diet. 
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Chapter 4 
DHA as a potential prophylactic treatment for semi-acute and 
chronic particle-induced inflammation in vivo  
 
4.1 Abstract 
Chronic inflammation is a vital contributing factor to pulmonary diseases which can be 
triggered by exposure to occupational and man-made particles. Unfortunately, there are no 
established treatments to block the cycle of chronic inflammation. One potential treatment 
shown to have anti-inflammatory capabilities is the dietary supplement docosahexaenoic 
acid (DHA); an omega-3 polyunsaturated fatty acid found in fish oil. DHA’s anti-
inflammatory mechanisms are unclear for particle-induced inflammation; therefore, this 
study evaluated DHA as a prophylactic treatment for semi-acute and chronic particle-
induced inflammation in vivo. Balb/c mice were fed a control or 1% DHA-containing diet 
for 5 weeks (semi-acute) or 18 weeks (chronic). At week 4 (semi-acute) or weeks 2, 3, 4, 
and 5 (chronic) the mice were oropharyngeal instilled with dispersion media, a highly 
inflammatory multi-walled carbon nanotube (MWCNT), or crystalline silica (SiO2). One 
week (semi-acute) or 13 weeks (chronic) after instillation inflammatory signaling within 
the lung lavage fluid, impacts on phagolysosomal membrane permeability, shifts of 
macrophage phenotype gene expression (M1, M2a, M2b, and M2c), and pulmonary 
histopathology were determined. Results indicated that DHA had a consistent anti-
inflammatory effect with mice exposed to MWCNT in both in vivo exposure models which 
could be linked to stabilizing the phagolysosomal membrane in alveolar macrophages and 
shifting macrophage phenotype in spleen tissue. Mice exposed to SiO2 while on the DHA 
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diet had varying effects which indicated that DHA treatment may depend upon certain 
inflammatory particle exposures. Therefore, DHA was shown to be effective, but the 
outcomes depend on the model under investigation. 
 
4.2 Introduction  
More than one billion people worldwide suffer from either acute or chronic respiratory 
conditions. This leads to respiratory diseases making up five of the thirty most common 
causes of death and over one billion people inhale polluted outdoor air; therefore, 
contributing to this respiratory impairment (Forum of International Respiratory Societies, 
2017). While the vast majority of concern with outdoor air pollution is related to fossil fuel 
combustion-generated particles; typically known as particulate matter less than 2.5 µm 
(PM2.5), there are many other occupational and man-made particles of specific concern that 
have a diameter of less than 2.5 µm and can travel down into the alveolar regions of the 
lung when inhaled. These include various engineered nanomaterials (ENM); such as multi-
walled carbon nanotubes (MWCNT), and crystalline silica (SiO2). 
The use of ENM has been rapidly increasing in many commercial products; such 
as cosmetics, electronics, and medicine (Ray et al., 2019). One of the most common ENM 
used for these products are MWCNT which are nano-sized, meaning that it has at least one 
dimension in the size range of 1–100 nm (Yokel & MacPhail, 2011). Some MWCNT have 
been linked to lung fibrosis and granuloma formation (Lam et al., 2006). In contrast to the 
nanosized MWCNT, SiO2 is a micron-sized particle primarily generated in occupational 
settings. Exposure to inhalable SiO2 particles (<10 μm in size) are known to cause silicosis; 
an established world-wide occupational health problem, and autoimmune disorders 
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(Pollard, 2016). However, there are no known prophylactic treatments to reduce 
inflammation caused by either of these particles.  
It has been reported that there has been a 60% increase between 2007 and 2012 in 
the dietary intake of fish oil supplementation (Clarke et al., 2015). Docosahexaenoic acid 
(DHA); an omega-3 polyunsaturated fatty acid that is found in fish oil, has been shown to 
have various anti-inflammatory capabilities. Studies have reported that DHA is beneficial 
throughout life; such as improving cognitive capabilities during fetal development and 
improving outcomes for cardiovascular disease and Alzheimer’s disease (Devassy et al., 
2016; Swanson et al., 2012). Nevertheless, research of how DHA effects particle-induced 
lung inflammation is currently limited. 
The objectives of the current studies were to evaluate the ability of DHA to reduce 
pulmonary inflammation caused by MWCNT and SiO2. The use of these two different 
particles provided the opportunity to examine the effects of DHA on particles with reported 
differences in immune mechanisms (Ray et al., 2019) within time courses that represented 
both moderate and high levels of particle doses. The studies used a 1% DHA prophylactic 
treatment; which has been previously shown to be effective in a Lupus-prone mouse model 
(Bates et al., 2016), but here we used the wildtype Balb/c murine model which is considered 
more Th2 prone (Watanabe et al., 2004). In addition to typical markers of lung 
inflammation we also examined shifts in macrophage phenotype in the lung and in the 
spleen for a systemic immune organ assessment. The hypothesis of this chapter is that DHA 
will decrease pulmonary inflammatory markers in response to particle-induced 
inflammation. In addition, the effects of DHA will be more effective in treating MWCNT 
than SiO2 in the Balb/c murine exposure model. 
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4.3 Results 
4.3.1 Effect of DHA on pulmonary cells and lung injury 
In order to simulate a semi-acute exposure model, Balb/c mice were placed on either a 
control or 1% DHA diet for a total of 5 weeks. At week 4, mice were oropharyngeal 
instilled once with either dispersion media-only vehicle (DM; 50 µl/mouse), MWCNT (50 
µg/mouse), or SiO2 (1 mg/mouse). One week after particle exposure, whole lung lavages 
were performed in order to collect immune cells that reside within the lung airspaces and 
assess inflammatory responses induced by particle exposure. The overall study design is 
depicted in Figure 13A. Confirmation of fatty acid composition within red blood cells was 
sent for analysis (Table 3) which confirmed an increase in DHA content within the DHA-
fed mice compared to the control diet (Figure 14A). 
The results of the semi-acute exposure model demonstrated that the mice had an 
increase in alveolar macrophages (AM) regardless of particle exposure and diet treatment 
(Figure 15A). There was no significant difference between the total number of cells when 
comparing the control diet and DHA diet for AM (data not shown). There was a slight 
increase in eosinophils and neutrophils in SiO2-exposed mice for both diets compared to 
other exposure groups; however, AM remained the dominant cell type (Figure 15A). Mice 
exposed to MWCNT while on the DHA diet had less cellular toxicity in the lung lavage 
fluid (LLF) compared to MWCNT mice on the control diet. This was shown by a trending 
decrease of LDH levels (Figure 15B); indicative of overall damage of pulmonary cells, and 
a trending decrease of protein concentration (Figure 15C); indicative of epithelial cell 
damage within the lungs. Analysis of inflammatory markers  
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Figure 13. Experimental designs of prophylactic semi-acute & chronic models. (A) Balb/c 
mice were put on a control or 1% DHA diet for 5 weeks. At week 4, mice were instilled with 
either DM-only, MWCNT, or SiO2 and euthanized 1 week later; semi-acute model. (B) Balb/c 
mice were put on a control or 1% DHA diet for 18 weeks. At weeks 2, 3, 4, & 5, mice were 
instilled with either DM-only, MWCNT, or SiO2 and euthanized 13 weeks later; chronic model. 
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Table 3. Fatty acid composition of red blood cells in prophylactic semi-acute model. Data 
presented in a percentage as mean ± SEM, n=3-5. 
 
 
 
 
 
 
 
 
P7d (Dr. Pestka’s Lab Analyzed): 
Note – only the January harvest (see reason in excel sheet) 
 
 
 
 
Experimental Groups 
Control Diet 1% DHA Diet 
DM MWCNT SiO2 DM MWCNT SiO2 
Fatty Acid % of fatty acid in RBC 
14:0  0.24 ± 0.03 0.29 ± 0.03 0.23 ± 0.03 0.31 ± 0.02 0.41 ± 0.03 0.45 ± 0.07 
15:0 0.07 ± 0.01 0.09 ± 0.01 0.08 ± 0.01 0.07 ± 0.00 0.08 ± 0.01 0.09 ± 0.01 
16:0 36.06 ± 0.83 33.98 ± 1.71 31.65 ± 0.62 37.07 ± 0.82 38.20 ± 1.15 38.71 ± 0.66 
16:1 (ω-7) trans 0.03 ± 0.01 0.04 ± 0.01 0.03 ± 0.01 0.02 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 
16:1 (ω-7) cis 0.33 ± 0.01 0.25 ± 0.02 0.30 ± 0.04 0.40 ± 0.04 0.50 ± 0.03 0.46 ± 0.06 
16:1 (ω-9) 0.24 ± 0.02 0.25 ± 0.03 0.22 ± 0.02 0.15 ± 0.01 0.22 ± 0.03 0.20 ± 0.01 
17:0 0.22 ± 0.02 0.27 ± 0.02 0.21 ± 0.03 0.21 ± 0.01 0.23 ± 0.03 0.22 ± 0.02 
18:0 19.16 ± 0.59 18.31 ± 1.55 16.85 ± 0.89 14.06 ± 0.95 16.14 ± 1.73 15.67 ± 0.88 
18:1 (ω-9) 17.30 ± 0.29 16.18 ± 0.34 16.10 ± 0.18 14.78 ± 0.48 15.48 ± 0.36 15.65 ± 0.44 
18:1 (ω-7) 1.25 ± 0.08 0.96 ± 0.04 1.17 ± 0.12 0.86 ± 0.03 1.10 ± 0.09 1.04 ± 0.11 
18:2 (ω-6) 5.19 ± 0.23 5.66 ± 0.21 5.48 ± 0.28 7.80 ± 0.13 6.90 ± 0.70 7.21 ± 0.28 
18:3 (ω-3) 0.44 ± 0.03 0.45 ± 0.03 0.40 ± 0.01 0.25 ± 0.01 0.24 ± 0.03 0.23 ± 0.01 
20:0 0.18 ± 0.03 0.21 ± 0.03 0.17 ± 0.02 0.17 ± 0.03 0.15 ± 0.04 0.15 ± 0.03 
20:4 (ω-6) 13.05 ± 0.69 15.51 ± 1.96 18.17 ± 0.91 5.14 ± 0.27 5.07 ± 0.31 4.69 ± 0.36 
20:5 (ω-3) 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 1.88 ± 0.18 1.75 ± 0.31 1.73 ± 0.17 
22:0 0.89 ± 0.04 0.82 ± 0.09 1.01 ± 0.11 0.70 ± 0.04 0.76 ± 0.01 0.68 ± 0.05 
22:4 (ω-6) 1.54 ± 0.08 1.66 ± 0.20 1.84 ± 0.11 0.31 ± 0.02 0.27 ± 0.04 0.29 ± 0.00 
22:5 (ω-6) 1.63 ± 0.09 1.83 ± 0.22 1.96 ± 0.20 0.21 ± 0.04 0.16 ± 0.04 0.16 ± 0.02 
22:5 (ω-3) 0.10 ± 0.01 0.14 ± 0.03 0.16 ± 0.03 0.46 ± 0.02 0.43 ± 0.02 0.42 ± 0.02 
22:6 (ω-3) 1.79 ± 0.16 2.47 ± 0.49 3.16 ± 0.22 14.58 ± 0.96 11.31 ± 1.37 11.26 ± 0.85 
24:0 0.14 ± 0.01 0.15 ± 0.00 0.12 ± 0.01 0.18 ± 0.01 0.17 ± 0.02 0.17 ± 0.00 
24:1 (ω-9) 0.09 ± 0.02 0.09 ± 0.01 0.07 ± 0.01 0.08 ± 0.01 0.08 ± 0.01 0.07 ± 0.00 
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Figure 14. Fatty acid analysis within red blood cells of prophylactic semi-acute & chronic 
models. Percentage of DHA content between control and 1% DHA diet for prophylactic (A) 
semi-acute and (B) chronic exposure models. Data presented as mean ± SEM, semi-acute n=11-
13, chronic n=4. *P<0.05, **P<0.01 compared to DM; ++++P<0.0001 compared to different 
treatments within the same exposure group. 
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Figure 15. Pulmonary cells and lung injury analysis in prophylactic semi-acute model. 
Balb/c mice were put on a control or 1% DHA diet for 5 weeks. At week 4, mice were 
instilled with either DM-only, MWCNT, or SiO2 and euthanized 1 week later. (A) 
Percentage of cell types were assessed via cytospins of cell differentials. (B) LDH and (C) 
protein concentration were assessed in the LLF for lung damage. Data presented as mean 
± SEM, n=7-9. *P<0.05, **P<0.01, ****P<0.0001 compared to DM, + compared to different 
diet within the same exposure group. Analyses were done with log-transformed data. 
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in the LLF showed an overall decrease of inflammatory signaling in the DHA-fed mice 
when exposed to MWCNT compared to the MWCNT control diet-fed mice; specifically, 
a significant decrease of IL-1β and TNFα as well as decreased levels of IFNγ, IL-33, and 
IL-6 (Figure 16). In contrast, mice exposed to SiO2 while on the DHA diet had a significant 
increase of LDH levels (Figure 15B) and a trending increase of protein concentration 
(Figure 15C) compared to the control diet-fed mice. These results positively correlated to 
a significant increase of IFNγ levels within the LLF as well as a trending increase of TNFα, 
IL-33, and IL-6 levels for these same mice (Figure 16). The increased neutrophils and 
eosinophils in SiO2-exposed mice could account for these differences in lung injury. These 
results showed that mice with a semi-acute particle exposure to MWCNT while on a 
prophylactic 1% DHA diet had decreased lung injury compared to the control diet; 
however, there was increased lung damage when mice were exposed to SiO2 while on the 
same DHA diet. This supported our hypothesis that DHA will decrease pulmonary 
inflammatory markers more effectively in MWCNT-exposed mice compared to SiO2-
exposed mice. 
 To simulate a chronic exposure study, Balb/c mice were placed on either a control 
or 1% DHA diet for a total of 18 weeks. At weeks 2, 3, 4, and 5, mice were oropharyngeal 
instilled once a week with either DM-only vehicle, MWCNT, or SiO2 as described above. 
Thirteen weeks after particle exposure, whole lung lavages were performed and analysis 
was completed the same as described above in the semi-acute model. The overall study 
design is depicted in Figure 13B. Confirmation of fatty acid composition within red blood 
cells was sent for analysis (Table 4) which confirmed an  
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Figure 16. Cytokine analysis in prophylactic semi-acute model. Balb/c mice were put on a 
control or 1% DHA diet for 5 weeks. At week 4, mice were instilled with either DM-only, 
MWCNT, or SiO2 and euthanized 1 week later. Inflammatory cytokines; IFNγ, IL-1β, 
TNFα, IL-33, pro-resolving cytokines; IL-10, and IL-13, and IL-6 were analyzed in the 
LLF. Data presented as mean ± SEM, n=8-9. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 
compared to DM, + compared to different diet within the same exposure group. Analyses 
were done with log-transformed data. 
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Table 4. Fatty acid composition of red blood cells in prophylactic chronic model. Data 
presented in a percentage as mean ± SEM, n=4. 
 
 
 
 
 
 
 
PC (OmegaQuant): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Groups 
Control Diet 1% DHA Diet 
DM MWCNT SiO2 DM MWCNT SiO2 
Fatty Acid % of fatty acid in RBC 
14:0 0.14 ± 1.05E-04 0.15 ± 5.74E-05 0.13 ± 1.64E-04 0.28 ± 1.28E-04 0.31 ± 1.37E-04 0.28 ± 1.72E-04 
16:0 27.16 ± 3.65E-03 27.85 ± 4.65E-04 27.61 ± 2.26E-03 30.90 ± 7.81E-04 30.21 ± 2.31E-03 31.69 ± 4.82E-04 
16:1 (ω-7) trans 0.10 ± 1.09E-04 0.09 ± 2.71E-04 0.12 ± 1.82E-04 0.06 ± 2.70E-04 0.08 ± 2.14E-04 0.09 ± 1.33E-04 
16:1 (ω-7) 0.31 ± 5.16E-04 0.34 ± 4.61E-04 0.31 ± 7.04E-04 0.31 ± 4.32E-04 0.36 ± 7.35E-04 0.39 ± 8.26E-04 
18:0 11.79 ± 2.16E-03 11.19 ± 1.12E-03 11.29 ± 2.48E-03 10.52 ± 1.91E-03 10.54 ± 2.63E-03 10.09 ± 2.07E-03 
18:1 trans 0.21 ± 3.03E-04 0.22 ± 2.38E-04 0.24 ± 1.90E-04 0.25 ± 3.63E-04 0.21 ± 1.60E-04 0.22 ± 1.28E-04 
18:1 (ω-9) 19.67 ± 2.95E-03 20.40 ± 1.57E-03 20.27 ± 2.35E-03 18.55 ± 1.68E-03 18.49 ± 3.72E-03 18.90 ± 5.36E-03 
18:2 (ω-6) trans 0.20 ± 1.63E-04 0.20 ± 2.72E-04 0.32 ± 3.70E-04 0.28 ± 5.57E-04 0.27 ± 8.06E-04 0.23 ± 4.07E-04 
18:2 (ω-6) 6.60 ± 5.35E-03 6.22 ± 6.01E-03 6.78 ± 7.16E-03 9.20 ± 3.52E-03 9.02 ± 1.79E-03 8.46 ± 4.30E-03 
18:3 (ω-6) 0.07 ± 3.72E-05 0.09 ± 2.71E-05 0.07 ± 6.95E-05 0.07 ± 8.99E-05 0.03 ± 5.12E-05 0.06 ± 5.60E-05 
18:3 (ω-3) 0.09 ± 1.42E-04 0.10 ± 8.20E-05 0.13 ± 1.93E-04 0.13 ± 2.19E-04 0.13 ± 1.01E-04 0.12 ± 2.34E-04 
20:0 0.18 ± 2.67E-04 0.17 ± 2.98E-04 0.20 ± 4.95E-04 0.20 ± 3.30E-04 0.20 ± 3.62E-04 0.19 ± 4.18E-04 
20:1 (ω-9) 0.54 ± 5.01E-04 0.59 ± 8.76E-04 0.59 ± 1.10E-03 0.43 ± 4.83E-04 0.45 ± 6.83E-04 0.42 ± 4.07E-04 
20:2 (ω-6) 0.15 ± 1.04E-04 0.15 ± 9.35E-05 0.15 ± 1.62E-04 0.14 ± 6.02E-05 0.16 ± 1.29E-04 0.15 ± 1.61E-04 
20:3 (ω-6) 1.12 ± 3.35E-04 1.04 ± 2.03E-04 1.03 ± 2.84E-04 1.19 ± 9.82E-05 1.18 ± 2.49E-04 1.31 ± 6.25E-04 
20:4 (ω-6) 21.87 ± 5.97E-03 21.47 ± 1.13E-02 21.07 ± 1.16E-02 5.06 ± 9.52E-04 4.76 ± 1.50E-03 5.30 ± 4.08E-03 
20:5 (ω-3) 0.04 ± 6.00E-05 0.03 ± 2.56E-05 0.03 ± 7.14E-05 2.63 ± 3.65E-03 2.65 ± 3.93E-03 2.65 ± 3.87E-03 
22:0 0.19 ± 1.08E-04 0.17 ± 1.50E-04 0.17 ± 2.51E-04 0.20 ± 1.05E-04 0.15 ± 6.36E-05 0.16 ± 1.84E-04 
22:4 (ω-6) 2.33 ± 1.58E-03 2.41 ± 7.04E-04 2.38 ± 6.67E-04 0.13 ± 8.04E-05 0.15 ± 2.70E-04 0.11 ± 1.76E-04 
22:5 (ω-6) 4.41 ± 7.76E-03 4.37 ± 9.18E-03 4.26 ± 7.17E-03 0.02 ± 7.14E-05 0.03 ± 3.01E-05 0.02 ± 1.07E-04 
22:5 (ω-3) 0.07 ± 5.71E-05 0.08 ± 1.41E-04 0.08 ± 8.38E-05 0.55 ± 3.15E-04 0.59 ± 2.83E-04 0.61 ± 5.56E-04 
22:6 (ω-3) 2.14 ± 1.76E-03 2.10 ± 3.03E-03 2.20 ± 3.44E-03 18.27 ± 4.48E-03 18.57 ± 4.95E-03 18.10 ± 5.98E-03 
24:0 0.20 ± 8.33E-05 0.19 ± 4.50E-05 0.18 ± 3.89E-04 0.24 ± 9.70E-05 0.19 ± 8.79E-05 0.19 ± 1.73E-04 
24:1 (ω-9) 0.42 ± 1.81E-04 0.37 ± 2.46E-04 0.38 ± 7.27E-04 0.39 ± 2.95E-04 0.28 ± 9.04E-05 0.24 ± 9.95E-05 
 68 
increase in DHA content within the DHA-fed mice compared to the control diet (Figure 
14B). 
The results of the chronic exposure model showed that the dominant cell type 
within the LLF was AM regardless of diet and particle exposure; however, there was also 
a slight overall increase in lymphocytes (Figure 17A). The SiO2-exposed mice also had an 
increase in neutrophils regardless of diet (Figure 17A) compared to the other exposure 
groups which was similar to the semi-acute study. Mice on the DHA diet and exposed to 
MWCNT had trending decreased lung damage as assessed by LDH (Figure 17B) and 
protein concentration (Figure 17C) within the LLF. These results also matched a decrease 
in overall inflammatory cytokines within the LLF for the same treatment and exposure 
groups; specifically, a significant decrease of TNFα and a decrease of IFNγ, IL-1β, IL-33, 
and IL-6 levels (Figure 18). The SiO2-exposed mice while on the DHA diet had increased 
lung damage (significantly increased LDH levels; Figure 17B, and increased protein 
concentration; Figure 17C) as well as increased inflammatory cytokines (Figure 18). 
However, IL-1β levels within the LLF of SiO2-exposed mice on the DHA diet were 
decreased compared to control diet. These results indicated that mice on the prophylactic 
1% DHA diet with a chronic particle exposure to MWCNT had less lung damage compared 
to the control-fed mice; however, the same DHA treatment was not protective of mice 
exposed to SiO2 which also supported our hypothesis. 
 
 
 
 
 69 
 
 
Figure 17. Pulmonary cells and lung injury analysis in prophylactic chronic model. Balb/c 
mice were put on a control or 1% DHA diet for 18 weeks. At weeks 2, 3, 4, & 5, mice were 
instilled with either DM-only, MWCNT, or SiO2 and euthanized 13 weeks later. (A) 
Percentage of cell types were assessed via cytospins of cell differentials. (B) LDH and (C) 
protein concentration were assessed in the LLF for lung damage. Data presented as mean 
± SEM, n=4-5. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to DM, + compared 
to different diet within the same exposure group. Analyses were done with log-transformed 
data. 
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Figure 18. Cytokine analysis in prophylactic chronic model. Balb/c mice were put on a 
control or 1% DHA diet for 18 weeks. At weeks 2, 3, 4, & 5, mice were instilled with either 
DM-only, MWCNT, or SiO2 and euthanized 13 weeks later. Inflammatory cytokines; 
IFNγ, IL-1β, TNFα, IL-33, pro-resolving cytokines; IL-10, and IL-13, and IL-6 were 
analyzed in the LLF. Data presented as mean ± SEM, n=4-5. *P<0.05, **P<0.01, 
***P<0.001, ****P<0.0001 compared to DM, + compared to different diet within the same 
exposure group. Analyses were done with log-transformed data. 
 
 
 
 
 
 
 
 
 
 71 
4.3.2 Alteration of LMP due to DHA 
As expected, AM were the dominate cell present within the LLF of the mice for both the 
semi-acute and chronic exposure models. AM are the primary innate immune cell in the 
lung responsible for the clearing of foreign material; such as inhalation of MWCNT and 
SiO2. When AM phagocytose these particles it can lead to phagolysosomal membrane 
permeabilization (LMP) which releases various lysosome-specific proteases; such as 
cathepsins, into the cytosol. In turn, this initiates NLRP3 inflammasome activation; which 
has been associated with the presence of cathepsin B in particular, eventually leading to 
IL-1β release (Schroder & Tschopp, 2010; Strowig et al., 2012). Therefore, isolated AM 
were cultured ex vivo to measure IL-1β release and the presence of cathepsins within the 
LLF were measured to potentially explain the differences between particles in the 
responses to DHA treatment. 
The semi-acute particle exposure model indicated that there was a significant 
decrease in IL-1β release ex vivo from AM for DHA mice exposed to DM-only compared 
to control diet (Figure 19A); however, there was no difference between diets for total 
cathepsin release (Figure 19B) and a slight increase in cathepsin B release (Figure 19C) for 
these same mice. There were no differences between diets when exposed to either particle 
for IL-1β release ex vivo from AM (Figure 19A), total cathepsin levels within the LLF 
(Figure 19B), or cathepsin B release within the LLF (Figure 19C). These results suggested 
that the prophylactic 1% DHA treatment did not appear to significantly affect the 
phagolysosomal membrane at this particular timepoint in Balb/c mice for a semi-acute 
particle exposure. 
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Figure 19. Assessment of LMP in prophylactic semi-acute model. Balb/c mice were put on 
a control or 1% DHA diet for 5 weeks. At week 4 mice were instilled with either DM-only, 
MWCNT, or SiO2 and euthanized 1 week later. LMP was assessed through detection of 
(A) IL-1β release directly from AM ex vivo, (B) cathepsin release within the LLF, and (C) 
cathepsin B release within the LLF. Data presented as mean ± SEM, n=5-7 (A), n=8-9 
(B,C). *P<0.05, **P<0.01, ***P<0.001 ****P<0.0001 compared to DM, + compared to 
different diet within the same exposure group. Analyses were done with log-transformed 
data. CTS; cathepsin. 
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Figure 20. Assessment of LMP in prophylactic chronic model. Balb/c mice were put on a 
control or 1% DHA diet for 18 weeks. At weeks 2, 3, 4, & 5, mice were instilled with either 
DM-only, MWCNT, or SiO2 and euthanized 13 weeks later. LMP was assessed through 
detection of (A) IL-1β release directly from AM ex vivo, (B) cathepsin release within the 
LLF, and (C) cathepsin B release within the LLF. Data presented as mean ± SEM, n=4-5. 
*P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to DM, + compared to different 
diet within the same exposure group. Analyses were done with log-transformed data. CTS; 
cathepsin. 
 
 
 
 
 74 
For the chronic particle exposure model, there was a significant decrease in IL-1β 
release ex vivo from AM of the DHA-fed mice regardless of particle exposure (Figure 
20A). This decreased trend continued when total cathepsin and cathepsin B levels were 
assessed within the LLF of SiO2-exposed mice while on the DHA diet (Figure 20 B,C). 
These results positively correlate to the decreased IL-1β release within the LLF as 
described earlier (Figure 18) for these same mice. Mice exposed to MWCNT had no 
difference between diets for total cathepsin release (Figure 20B), but had a slight decrease 
of cathepsin B release (Figure 20C) within the LLF. These results indicated that a long-
term prophylactic 1% DHA diet improved the stability of the phagolysosomal membrane 
during a chronic exposure to inflammatory particles when compared to the control diet 
supporting our hypothesis that DHA could decrease pulmonary inflammatory markers.  
 
4.3.3 DHA shifts macrophage phenotype 
Since DHA treatment had effects on AM that varied between the different particle exposure 
models, alterations of macrophage phenotypes were assessed. Various signaling factors; 
such as cytokines and immune complexes, generate different macrophage phenotypes that 
are broadly defined as classically activated, “pro-inflammatory” M1 and alternatively 
activated, “anti-inflammatory” M2. The signaling factors determine which macrophage 
phenotype is dominant to regulate the overall response to foreign particles. Depending on 
the overall environment present during particle exposure, macrophages could either be 
aiding in inflammation or suppressing inflammation through phenotype shifts (Byrne et al., 
2015; Italiani & Boraschi, 2014; Labonte et al., 2014). Information on the impacts of DHA 
with macrophage phenotype in regard to particle-induced inflammation is lacking, 
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especially when analyzing the understudied M2b and M2c subsets. Therefore, macrophage 
phenotypes were evaluated within the lung and spleen tissues to determine local and 
systemic effects since recent studies in our laboratory have shown trafficking of MWCNT 
into the spleen and changes in immune cell populations. There will be a mixture of 
macrophage phenotypes present under any condition, therefore it is important to appreciate 
that these studies represent a snap-shot in time to assess the shifts in phenotype between 
particle exposure as well as DHA treatment. 
When the effect of particle-only exposure was assessed within the lung tissue of 
the semi-acute model there was a downregulation of gene expression for the majority of 
the macrophage phenotype markers (Figure 21A). The DHA diet altered this gene 
expression within the lung tissue by bringing most of those same genes closer to baseline 
levels, indicating that the gene expressions were similar for both control and DHA-fed 
mice. There were various genes that were upregulated by DHA treatment in the lung tissue 
as well; however, not enough to clearly distinguish a specific macrophage phenotype shift 
at this particular timepoint (Figure 21B). The particle-only effect within the spleen tissue 
of mice exposed to MWCNT had a trending upregulation in the M1 markers described as 
an increase in two of the four genes. Within the spleen tissue of mice exposed to SiO2 there 
was a dominant upregulation in gene expression markers for the M1 phenotype as indicated 
by an increase of at least three of the four genes. These same mice also had a trending 
upregulation in M2a markers (Figure 21C). Exposure to the DHA diet altered these 
phenotypes within the spleen tissue by downregulating gene expression of the M1 markers 
for both MWCNT and SiO2 exposures indicating a 
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Figure 21. Impact of particle exposure and DHA treatment on macrophage phenotype in 
prophylactic semi-acute model. Balb/c mice were put on a control or 1% DHA diet for 5 
weeks. At week 4, mice were instilled with either DM-only, MWCNT, or SiO2 and 
euthanized 1 week later. Relative gene expression of control diet MWCNT or SiO2 mice 
were normalized to control diet DM-only mice for assessment of particle effect in (A) lung 
and (C) spleen tissue. Relative gene expression of 1% DHA diet mice were normalized to 
corresponding control diet mice for assessment of diet effect in (B) lung and (D) spleen 
tissue. Each bar within the heat maps consist of 5-6 mice for lung tissue and 4-5 mice for 
spleen tissue. 
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decrease in the pro-inflammatory phenotype, supporting our hypothesis (Figure 21D). 
Gene expression levels were upregulated in various M2 markers for both particle exposure 
groups; however, not enough to distinguish one particular M2 subset as dominant in the 
spleen tissue at this time. These results indicated that the prophylactic 1% DHA treatment 
brought the gene expression levels back to baseline more rapidly within the lung tissue 
during a semi-acute particle exposure. It also suggested that DHA decreased the 
inflammatory markers within the spleen tissue of these same mice. 
The particle-only effect within the lung tissue of the chronic model showed a 
dominant downregulation of almost all gene expressions regardless of macrophage 
phenotype or particle exposure. A few genes were upregulated within each phenotype 
separately of these mice; however, not enough to distinguish a specific phenotype shift 
(Figure 22A). DHA treatment in the lung tissue did not alter the macrophage phenotype of 
MWCNT-exposed mice, but it did change in the SiO2-exposed mice which showed a 
trending upregulation for the M2b subset (Figure 22B). The particle-only effects within the 
spleen tissue of MWCNT-exposed mice were a mixture of either closer to baseline levels 
or downregulated gene expression. However; for SiO2-exposed mice there was a trending 
upregulation in M2b gene expression in the spleen tissue (Figure 22C). DHA treatment 
altered these gene expression levels in the spleen tissue by having a dominant macrophage 
phenotype shift towards the M2c phenotype for both DM-only and MWCNT exposure 
groups. Upon DHA treatment in the spleen tissue, there was a dominant macrophage 
phenotype shift towards M2a and a trending upregulation of M2c for SiO2-exposed mice 
(Figure 22D). Both the M2a and M2c phenotypes have overlapping marker  
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Figure 22. Impact of particle exposure and DHA treatment on macrophage phenotype in 
prophylactic chronic model. Balb/c mice were put on a control or 1% DHA diet for 18 
weeks. At weeks 2, 3, 4, & 5, mice were instilled with either DM-only, MWCNT, or SiO2 
and euthanized 13 weeks later. Relative gene expression of control diet MWCNT or SiO2 
mice were normalized to control diet DM-only mice for assessment of particle effect in (A) 
lung and (C) spleen tissue. Relative gene expression of 1% DHA diet mice were normalized 
to corresponding control diet mice for assessment of diet effect in (B) lung and (D) spleen 
tissue. Each bar within the heat maps consist of 4-5 mice for lung tissue and 4 mice for 
spleen tissue. 
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characteristics indicative of tissue repair and matrix deposition. These results indicated that 
the prophylactic 1% DHA treatment shifted the macrophage phenotype into a repair phase 
within the spleen tissue; even with a chronic inflammatory particle exposure. 
 
4.3.4 Effect of DHA on lung histopathology 
The above results confirmed that DHA decreased various inflammatory signaling cascades 
within the LLF and altered the gene expression of macrophage phenotypes within tissues. 
Both of which had different outcomes that were dependent upon the type of particle and 
length of DHA treatment. This indicated that it would be important to determine if DHA 
impacted particle-induced lung pathology. Lung tissue sections from these mice were 
trichrome-stained for histological changes and airway thickness was measured. The degree 
of lung disease was scored on a 5-point scale system (0, 1, 2, 3, 4) with 0 being no effect 
and 4 indicating extreme lung pathology as described within Chapter 2. 
 When comparing the control and DHA diet-fed mice for pulmonary pathology 
analysis, there was a significant increase in pulmonary inflammation of the DHA-fed mice 
when exposed to MWCNT in the semi-acute model (Figure 23A). However, there were no 
differences in pathology scoring compared between diets for either the DM-only or SiO2 
exposure groups. When assessing airway thickness upon DHA treatment, there was a 
decrease for the MWCNT-exposed group as well as significant decreases for both DM-
only and SiO2-exposed mice (Figure 23B). Representative photomicrographs of these 
findings are shown in Figure 23C. These results indicated that the prophylactic 1%  
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Figure 23. Histopathology analysis of lung tissue in prophylactic semi-acute model. Balb/c 
mice were put on a control or 1% DHA diet for 5 weeks. At week 4, mice were instilled 
with either DM-only, MWCNT, or SiO2 and euthanized 1 week later. (A) Pathology was 
scored blinded by a board-certified veterinary pathologist, (B) airway thickness was 
measured blinded, and (C) representative images (10x) of Gömöri’s trichrome-stained lung 
airway sections. Data presented as mean ± SEM, n=3.  *P<0.05, **P<0.01 compared to DM, 
+ compared to different diet within the same exposure group. Arrows indicate particle 
encapsulation, arrow heads indicate increased lung airway thickness, and blue staining 
indicates collagen deposition. 
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DHA treatment decreased airway thickness when compared to control mice, regardless of 
a semi-acute exposure to inflammatory particles. 
In the chronic model, DHA significantly decreased pulmonary inflammation with 
DM-only exposure when compared to the control diet (Figure 24A) and had a 
corresponding slight decrease in airway thickness (Figure 24B). DHA had a significant 
increase of pulmonary inflammation for mice exposed to MWCNT compared to the control 
diet-fed mice (Figure 24A) as well as trending increased airway thickness (Figure 24B). 
SiO2-exposed mice on the DHA diet had increased pulmonary inflammation when 
compared to the control diet (Figure 24A), but there was no change between diets when 
airway thickness was assessed (Figure 24B). Representative photomicrographs of these 
findings are shown in Figure 24C. These results indicated that a chronic exposure to 
particles created increased inflammation; especially with SiO2, regardless of diet. The 
prophylactic 1% DHA treatment did not appear beneficial for lung histopathology at this 
particular timepoint. However, it should be noted that the total particle dose was four-times 
higher in the chronic exposure model compared to the semi-acute model. This may 
contribute to the differences between the two exposure models where the chronic model is 
more representative of a long-term occupational exposure.  
 
4.4 Discussion  
Occupational exposure to SiO2 can lead to silicosis and autoimmune diseases. In contrast, 
there are no confirmed human diseases resulting from MWCNT exposures at this time. 
However, both particles can lead to lung inflammation in animal models and with the 
widespread use of various ENM has increase for concern. MWCNT serves as an  
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Figure 24. Histopathology analysis of lung tissue in prophylactic chronic model. Balb/c 
mice were put on a control or 1% DHA diet for 18 weeks. At weeks 2, 3, 4, & 5, mice were 
instilled with either DM-only, MWCNT, or SiO2 and euthanized 13 weeks later. (A) 
Pathology was scored blinded by two observers; data presented as median ± SEM. (B) 
Airway thickness was measured blinded; data presented as mean ± SEM. (C) 
Representative images (10x) of Masson’s trichrome-stained lung airway sections. n=3;  
*P<0.05, **P<0.01, ***P<0.001 compared to DM, + compared to different diet within the 
same exposure group. Arrows indicate particle encapsulation, asterisks indicate lesion 
formation, and blue staining indicates collagen deposition. 
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important inflammatory model since it has been reported to cause eosinophilic 
inflammation linked to asthma (Carvalho et al., 2018) which also appears to be more 
sensitive in female mice (Ray & Holian, 2019). The differences between the MWCNT- 
and SiO2-exposed mice with DHA treatment throughout the current studies could be 
attributed to a number of variables such as size, surface charge, surface wettability, 
morphology, persistence in the lung, or even composition. MWCNT are man-made rolled 
graphene sheets in the size range of 1–100 nm in at least one dimension with a high surface 
area per mass and they are very hydrophobic (Saifuddin et al., 2013). SiO2, on the other 
hand, is commonly found in nature as quartz which can be fractured to be a respirable size 
of <10 μm and are considered hydrophilic on the surface (Dyachenko et al., 2004; Pollard, 
2016). Unfortunately, established prophylactic or therapeutic treatments are lacking for 
inflammatory diseases caused by these particles. The goal of these studies was to assess if 
DHA; an omega-3 polyunsaturated fatty acid known to have anti-inflammatory effects, 
could potentially decrease inflammation induced by MWCNT or SiO2 in semi-acute and 
chronic exposures for a wildtype murine model. Therefore; inflammatory signaling within 
the LLF, lung histopathology analysis, the occurrence of LMP, and macrophage phenotype 
shifts were performed in these studies. 
It has been shown that exposure to MWCNT or SiO2 causes an increase in 
inflammatory cytokines as well as increased lung pathology (Pollard, 2016; Hamilton et 
al., 2012; Jessop et al., 2017). Various studies have reported that feeding fish oil to mice 
decreased inflammatory cytokine production, such as TNF, IL-1β, and IL-6 (Bhattacharya 
et al., 2007; Calder, 2015; Xi et al., 1998). There is also evidence suggesting that DHA 
treatment can protect against SiO2-triggered autoimmunity within kidney and lung tissue 
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in a lupus-prone mouse model (Bates et al., 2016). Omega-3 fatty acid supplementation 
demonstrated a protective effect in lung pathology when exposed to fine particulate matter 
in both C57BL/6 and transgenic Fat-1 mice (X.-Y. Li et al., 2017). However, murine strains 
vary in their responses and there is limited research when assessing cytokine analysis and 
lung pathology for particle-induced inflammation with DHA treatment using a Balb/c 
mouse model. Therefore, the current studies were designed to address that gap of 
knowledge. The current results indicated a consistent decrease of inflammatory cytokine 
levels within the LLF of DHA-treated mice when exposed to MWCNT in both the semi-
acute and chronic exposure models. A decrease in airway thickness was also observed in 
the semi-acute model when exposed to MWCNT with DHA treatment. In contrast, mice 
that were exposed to SiO2 with DHA treatment showed a consistent increase of most 
inflammatory cytokine levels within the LLF. Lung pathology was severe regardless of 
diet throughout both studies within these same mice as well. These results confirmed our 
hypothesis that DHA decreased pulmonary inflammatory markers which was beneficial to 
the MWCNT-exposed mice, but less obvious for SiO2-treated mice. This indicated that 
DHA as a beneficial prophylactic treatment may depend upon certain inflammatory particle 
exposures which could be attributed to the various physiochemical differences between the 
two types of particles as mentioned above. 
Exposure to MWCNT and SiO2 have been linked to LMP which mechanistically 
leads to NLRP3 inflammasome activation resulting in lung inflammation. One study has 
indicated that MWCNT increased NLRP3 inflammasome activation in THP-1 cells and 
primary human blood monocytes (Svadlakova et al., 2020). It was also shown that 
MWCNT induced HMGB1 secretion within LLF of C57BL/6 mice which contributed to 
 85 
signal 1 of NLRP3 inflammasome activation (Jessop & Holian, 2015). It is well-known 
that SiO2 exposure also activates the NLRP3 inflammasome (Dostert et al., 2008; Hornung 
et al., 2008). DHA treatment of THP-1 cells using LPS as a stimulus of signal 1 showed a 
decrease in NLRP3 inflammasome activation (Martínez-Micaelo et al., 2016; Williams-
Bey et al., 2014). The incorporation of DHA into phospholipids could alter lipid packing 
and membrane raft structure in lysosomal membranes which could affect membrane 
stability and LMP (Turk and Chapkin, 2013; Wassall et al., 2018). Unfortunately, there is 
little mechanistic information to determine if DHA decreases particle-induced LMP, 
leading to decreased NLRP3 inflammasome activation. The current studies addressed the 
effects of DHA on particle-induced LMP by measuring total cathepsin release and 
cathepsin B release within the LLF as well as IL-1β release from AM ex vivo. There was 
no difference between diets with either particle exposure during the semi-acute model; 
however, DHA did decrease LMP markers for both particle exposures in the chronic model. 
This suggested that DHA could affect the phagolysosomal membrane with prolonged 
treatment resulting in changes in stability that accounted for decreased IL-1β release. This 
finding supported the hypothesis that DHA decreases pulmonary inflammatory markers. 
It has been reported that DHA decreased M1-like macrophage-associated markers 
while increasing anti-inflammatory cytokines within co-culture of adipocytes and 
RAW264.7 cells (De Boer et al., 2014). Another study indicated that DHA induced a M2-
like polarization via the PPARγ pathway in RAW264.7 cells (Chang et al., 2015). As for 
in vivo responses, C57BL/6J mice treated with DHA demonstrated that adipose tissue 
macrophages polarized towards a M2a-like phenotype (Titos et al., 2011). Another in vivo 
study showed that M2a markers were increased in an ischemic brain model of C57BL/6 
 86 
mice with DHA treatment (Cai et al., 2018). Much less is known about the alterations of 
macrophage phenotype in regard to particle exposure as well as the impacts of DHA 
treatment on these exposures. The current study aimed to determine if DHA could maintain 
it’s trending M2-like shift after exposure to various particles. In the semi-acute particle 
exposure model, both MWCNT and SiO2 upregulated the M1 phenotype markers in spleen 
tissue; however, DHA treatment downregulated these inflammatory gene expression 
markers. The chronic particle exposure model showed a trend of upregulated M2b gene 
expression markers for SiO2-exposed mice with DHA treatment in the lung tissue which 
could be attributed to the increased number of neutrophils found within the LLF. One study 
found that neutrophil efferocytosis induced a M2b phenotype in C57BL/6 bone marrow-
derived macrophages (Filardy et al., 2010). The current chronic study also showed an 
upregulation of M2a and M2c gene expression markers in the spleen tissue upon DHA 
treatment which are indicative of tissue repair. These results indicate that DHA treatment 
can downregulate inflammatory gene expression markers and upregulate pro-resolving and 
tissue repair within a particle exposure model which supports our hypothesis. These results 
also demonstrated that future macrophage phenotype research should not be confined to 
only the M1 and M2a phenotypes.  
 Information on the correlations between LMP and macrophage phenotype is scarce. 
It has been shown that both NLRP3 inflammasome and NOD2 were upregulated within 
the M1 phenotype of peripheral blood mononuclear cell-derived macrophages following 
LPS stimulation (Awad et al., 2017). Another study found that NLRP3 inflammasome 
inhibition shifted macrophages to a M2c-like phenotype in a nephrocalcinosis-related 
kidney disease model (Anders et al., 2018). This could potentially explain the results within 
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the current study showing decreased LMP in the chronic exposure model and increased 
M2c phenotype markers in the spleen tissue with DHA treatment within the same model. 
One possible explanation for these differences could be linked to the coordinated lysosomal 
expression and regulation (CLEAR) gene network and its gene transcription factor EB 
(TFEB). TFEB silencing is associated with the downregulation of eighteen out of twenty-
three lysosomal genes and found to regulate cathepsin B in HeLa cells (Sardiello et al., 
2009). The knockdown of TFEB promoted M2-like polarization via STAT3 activation 
within a tumor microenvironment of peritoneal macrophages (Fang et al., 2017). Our 
laboratory has recently seen differences between the various macrophage phenotypes and 
LMP which could correlate with alterations in TFEB.  
 These results suggested that DHA had a consistent anti-inflammatory effect on 
MWCNT-exposed Balb/c mice in a semi-acute and chronic exposure model which is linked 
to stabilizing the phagolysosomal membrane and alterations in macrophage phenotype 
formation. Exposure to SiO2 with DHA treatment was not as consistent throughout the 
exposure studies which indicates that DHA treatment may not be the correct fit for 
excessive SiO2-induced inflammation even though there were several promising outcomes. 
The findings support the notion that DHA could potentially be used as a prophylactic 
treatment and should be investigated further as a possible therapeutic treatment after 
particle exposure. 
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Chapter 5 
DHA as a potential therapeutic treatment for semi-acute and 
chronic particle-induced inflammation in vivo 
 
5.1 Abstract 
Docosahexaenoic acid (DHA) is an omega-3 polyunsaturated fatty acid that has been 
reported to suppress inflammation. Chronic pulmonary inflammation can be linked to 
exposure of various occupational and man-made particles which can lead to pulmonary 
diseases. The development of therapeutic treatments are lacking within the field of particle-
induced pulmonary inflammation; therefore, this study evaluated DHA as a potential 
therapeutic treatment for semi-acute and chronic particle-induced inflammation. Balb/c 
mice were oropharyngeal instilled with dispersion media, a highly inflammatory multi-
walled carbon nanotube (MWCNT), or crystalline silica (SiO2) at week 0 (semi-acute) or 
once a week at weeks 0, 1, 2, 3 (chronic). The mice were kept on the normal mouse chow 
during this time for each study. One week after the last particle instillation (week 1; semi-
acute, or week 4; chronic) the mice were placed on either a control or 1% DHA-containing 
diet for 3 weeks (semi-acute) or 12 weeks (chronic). Either 4 weeks (semi-acute) or 13 
weeks (chronic) after the last particle instillation inflammatory signaling within the lung 
lavage fluid, impacts on phagolysosomal membrane permeability, shifts of macrophage 
phenotype gene expression (M1, M2a, M2b, and M2c), and pulmonary histopathology 
were assessed. The results indicated that DHA was more protective as a therapeutic 
treatment in a chronic particle-exposure model; especially for MWCNT exposure. 
Exposure to SiO2 with DHA treatment was not as consistent throughout the exposure 
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studies. This indicated that the benefits of DHA treatment may depend not only upon the 
duration of treatment, but also the type of inflammatory particle exposure being treated. 
 
5.2 Introduction  
Two important families of polyunsaturated fatty acids (PUFA) are omega-6 and omega-3 
which encompass the essential fatty acids of linoleic and α-linolenic acids; respectively. 
These essential fatty acids are converted into other fatty acids within each PUFA family 
such as arachidonic (ARA) and docosahexaenoic (DHA) acids through various 
desaturation and elongation steps (Calder, 2017). Unfortunately, in most Western diets 
there is too much omega-6; in part due to high levels of consumption of red meat, and not 
enough of omega-3 which can be improved with consumption of fatty fish. This diet leads 
to an omega-6/-3 ratio of 10-20/1 where most adults intake less than 0.2 g/day of DHA 
(Calder, 2017; Molendi-Coste et al., 2011). Increased ARA content is linked to 
inflammation while exposure to omega-3 PUFAs; specifically DHA, has been reported to 
have various anti-inflammatory capabilities (Calder, 2017; Swanson et al., 2012). Recent 
research has suggested that omega-3 PUFAs suppress particle-induced pulmonary and 
systemic inflammation as well (X.-Y. Li et al., 2017; Bates et al., 2016). 
Respiratory diseases make up five of the thirty most common causes of death 
(Forum of International Respiratory Societies, 2017). It is known that exposure to airborne 
toxicants can cause acute and chronic inflammation within the lungs which can lead to 
serious inflammatory diseases; such as lung fibrosis, and contribute to autoimmune 
diseases (Wong et al., 2016). Two inhalable particles that are of concern are nano-sized 
multi-walled carbon nanotubes (MWCNTs) and micron-sized crystalline silica (SiO2). 
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MWCNTs have been linked to lung fibrosis and granuloma formation while exposure to 
inhalable SiO2 particles is known to cause silicosis and autoimmune disorders (Lam et al., 
2006; Pollard, 2016). Understanding the mechanisms of lung inflammation and the 
development of therapeutic treatments are lacking within the field of particle-induced 
pulmonary inflammation. Evidence has suggested that DHA blocked SiO2-triggered 
autoimmunity in autoimmune disease-prone NZBWF1 mice and that omega-3 PUFAs 
decreased inflammation in both C57BL/6 wild-type mice; which are Th1-prone, and a 
transgenic Fat-1 murine model with a C57BL/6 background (Bates et al., 2016; X.-Y. Li 
et al., 2017; Watanabe et al., 2004). However, assessing the effects of DHA treatment for 
particle-induced inflammation within a Balb/c murine model; which are Th2-prone 
(Watanabe et al., 2004), is currently limited. 
 Our laboratory recently assessed DHA as a potential prophylactic treatment in 
semi-acute and chronic particle exposure models of Balb/c mice. Results indicated that 
DHA had a consistent anti-inflammatory effect on MWCNT-exposed Balb/c mice in both 
exposure models which could be linked to stabilizing the phagolysosomal membrane 
and/or macrophage phenotype formation. Exposure to SiO2 with DHA treatment was not 
as consistent throughout the exposure studies; however, there were several promising 
outcomes. Those results indicated that DHA could potentially be used as a prophylactic 
treatment for particle-induced inflammation. 
The objectives of the current studies were to determine whether DHA could be used 
as a prospective therapeutic treatment within both semi-acute and chronic particle exposure 
models. Most research on DHA treatment is assessing it as a potential prophylaxis, but 
research of DHA as a possible therapeutic is scarce. In reality, treatment to inflammatory 
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diseases typically occurs after inflammation has ensued. Therefore, it is crucial to address 
this gap of knowledge in order to understand if DHA treatment could be used as a 
therapeutic for particle-induced inflammation. The hypothesis of this chapter is that DHA 
will decrease pulmonary inflammatory markers in response to particle-induced 
inflammation. In addition, the effects of DHA will be more effective in treating MWCNT 
than SiO2 in the Balb/c exposure model. 
 
5.3 Results 
5.3.1 Effect of DHA on pulmonary cells and lung injury 
A semi-acute model was used to assess the effects of DHA treatment following delivery of 
a short-term particle exposure and a chronic model to simulate a prolonged DHA treatment 
following a more substantial particle exposure model. The overall study designs are 
depicted in Figure 25 (semi-acute; A and chronic; B). Briefly, mice were anesthetized with 
isoflurane before instillation so as not to use any restraints or cause distress and then 
oropharyngeal instilled once with either dispersion media-only vehicle (DM; 50 µl/mouse), 
MWCNT (50 µg/mouse), or SiO2 (1 mg/mouse) at week 0 (semi-acute) or once a week at 
weeks 0, 1, 2, 3 (chronic). The mice were kept on the normal mouse chow during this time 
for each study. One week after the last particle instillation (week 1; semi-acute, or week 4; 
chronic) the mice were placed on either a control or 1% DHA-containing diet for 3 weeks 
(semi-acute) or 12 weeks (chronic). The mice were euthanized by a lethal dose of sodium 
pentobarbital either 4 weeks (semi-acute) or 13 
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Figure 25. Experimental designs of therapeutic semi-acute & chronic models. (A) Balb/c 
mice were instilled once with either DM, MWCNT (50 µg/mouse), or SiO2 (1 mg/mouse) 
at week 0, kept on the normal mouse chow for 1 week, and then put on either a control or 
1% DHA diet for 3 weeks; semi-acute. (B) Balb/c mice were instilled with either DM, 
MWCNT (50 µg/mouse), or SiO2 (1 mg/mouse) once a week at weeks 0, 1, 2, 3 while on 
the normal mouse chow and at week 4 were put on the control or 1% DHA diet for 12 
weeks; chronic. 
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Table 5. Fatty acid composition of red blood cells in therapeutic semi-acute model. Data 
presented in a percentage as mean ± SEM, n=4. 
 
 
 
 
 
 
 
 
 
T7d (OmegaQuant): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Groups 
Control Diet 1% DHA Diet 
DM MWCNT SiO2 DM MWCNT SiO2 
Fatty Acid % of fatty acid in RBC 
14:0 0.23 ± 1.82E-04 0.16 ± 9.51E-05 0.14 ± 1.11E-04 0.26 ± 1.48E-04 0.35 ± 3.02E-04 0.34 ± 5.19E-04 
16:0 28.26 ± 3.79E-03 26.61 ± 5.56E-03 26.78 ± 3.57E-03 29.49 ± 4.20E-03 29.95 ± 1.59E-03 30.74 ± 8.75E-04 
16:1 (ω-7) trans 0.06 ± 2.96E-05 0.06 ± 4.31E-05 0.06 ± 2.82E-05 0.05 ± 3.13E-05 0.05 ± 1.99E-05 0.07 ± 3.47E-05 
16:1 (ω-7) 0.39 ± 8.87E-04 0.33 ± 4.07E-04 0.34 ± 5.88E-04 0.38 ± 9.03E-04 0.44 ± 6.98E-04 0.27 ± 3.26E-04 
18:0 13.00 ± 4.68E-03 13.56 ± 5.43E-03 14.01 ± 6.80E-03 12.21 ± 4.24E-03 11.12 ± 6.77E-03 11.72 ± 1.63E-03 
18:1 trans 0.21 ± 2.71E-04 0.16 ± 7.32E-05 0.19 ± 5.55E-05 0.15 ± 1.43E-04 0.17 ± 1.40E-04 0.28 ± 7.69E-05 
18:1 (ω-9) 19.56 ± 5.18E-03 19.09 ± 5.74E-03 19.06 ± 6.78E-03 17.49 ± 1.76E-03 17.99 ± 4.84E-03 17.77 ± 2.58E-03 
18:2 (ω-6) trans 0.20 ± 1.59E-04 0.21 ± 2.20E-04 0.21 ± 1.89E-04 0.13 ± 1.17E-04 0.12 ± 6.63E-05 0.21 ± 1.28E-04 
18:2 (ω-6) 9.29 ± 1.20E-02 9.21 ± 3.50E-03 9.06 ± 6.84E-03 10.42 ± 6.52E-03 10.45 ± 6.78E-03 9.78 ± 2.77E-03 
18:3 (ω-6) 0.09 ± 1.12E-04 0.10 ± 6.90E-05 0.08 ± 6.18E-05 0.04 ± 2.33E-05 0.05 ± 5.23E-05 0.06 ± 4.14E-05 
18:3 (ω-3) 0.09 ± 1.27E-04 0.09 ± 1.23E-04 0.09 ± 1.05E-04 0.07 ± 6.33E-05 0.08 ± 4.13E-05 0.13 ± 1.29E-04 
20:0 0.22 ± 3.85E-04 0.20 ± 3.38E-04 0.21 ± 3.23E-04 0.20 ± 4.20E-04 0.20 ± 3.84E-04 0.19 ± 2.28E-04 
20:1 (ω-9) 0.55 ± 1.63E-04 0.57 ± 9.81E-05 0.56 ± 2.76E-04 0.38 ± 1.87E-04 0.39 ± 2.84E-04 0.44 ± 4.53E-04 
20:2 (ω-6) 0.20 ± 8.12E-05 0.21 ± 1.49E-04 0.20 ± 1.47E-04 0.18 ± 4.79E-05 0.17 ± 1.26E-04 0.19 ± 5.86E-05 
20:3 (ω-6) 1.02 ± 1.56E-03 1.19 ± 8.05E-04 1.26 ± 1.17E-03 1.06 ± 8.12E-04 1.03 ± 8.75E-04 1.03 ± 8.40E-04 
20:4 (ω-6) 17.75 ± 7.93E-03 18.74 ± 3.25E-03 18.48 ± 9.94E-03 7.70 ± 3.26E-03 7.44 ± 7.37E-03 8.33 ± 5.69E-03 
20:5 (ω-3) 0.05 ± 2.25E-05 0.06 ± 8.15E-05 0.05 ± 7.64E-05 1.57 ± 1.63E-03 1.79 ± 1.34E-03 1.44 ± 1.22E-03 
22:0 0.11 ± 1.49E-04 0.14 ± 1.59E-04 0.13 ± 6.88E-05 0.16 ± 1.28E-04 0.13 ± 6.85E-05 0.11 ± 1.16E-04 
22:4 (ω-6) 2.03 ± 1.19E-03 2.15 ± 6.17E-04 2.08 ± 1.17E-03 0.75 ± 3.95E-04 0.71 ± 1.81E-04 0.79 ± 6.04E-04 
22:5 (ω-6) 2.30 ± 3.60E-04 2.23 ± 5.11E-04 2.38 ± 7.53E-04 0.54 ± 5.56E-04 0.50 ± 1.99E-04 0.51 ± 4.64E-04 
22:5 (ω-3) 0.24 ± 3.96E-04 0.30 ± 4.98E-04 0.26 ± 3.12E-04 0.54 ± 1.09E-04 0.55 ± 2.56E-04 0.52 ± 1.57E-04 
22:6 (ω-3) 3.66 ± 2.65E-03 4.01 ± 1.13E-03 3.74 ± 1.83E-03 15.61 ± 4.21E-03 15.71 ± 6.03E-03 14.30 ± 5.33E-03 
24:0 0.24 ± 2.75E-04 0.32 ± 2.06E-04 0.30 ± 1.48E-04 0.34 ± 3.19E-04 0.33 ± 3.10E-04 0.45 ± 4.62E-04 
24:1 (ω-9) 0.26 ± 2.77E-04 0.31 ± 2.06E-04 0.33 ± 2.39E-04 0.29 ± 1.92E-04 0.27 ± 2.23E-04 0.34 ± 1.67E-04 
 95 
 
 
 
 
 
 
 
Table 6. Fatty acid composition of red blood cells in therapeutic chronic model. Data 
presented in a percentage as mean ± SEM, n=4. 
 
 
 
 
 
 
 
 
 
TC (OmegaQuant): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental Groups 
Control Diet 1% DHA Diet 
DM MWCNT SiO2 DM MWCNT SiO2 
Fatty Acid % of fatty acid in RBC 
14:0 0.14 ± 8.55E-05 0.17 ± 1.44E-04 0.17 ± 1.08E-04 0.25 ± 5.04E-05 0.27 ± 3.61E-05 0.24 ± 1.34E-04 
16:0 26.40 ± 2.36E-03 28.04 ± 2.42E-03 27.63 ± 2.34E-03 30.95 ± 3.65E-03 31.70 ± 3.47E-03 32.43 ± 2.87E-03 
16:1 (ω-7) trans 0.07 ± 1.36E-04 0.08 ± 7.46E-05 0.09 ± 1.71E-04 0.05 ± 9.95E-05 0.06 ± 1.01E-04 0.04 ± 7.27E-05 
16:1 (ω-7) 0.42 ± 2.58E-04 0.40 ± 2.03E-04 0.36 ± 2.88E-04 0.44 ± 4.09E-04 0.47 ± 5.24E-04 0.39 ± 2.80E-04 
18:0 13.48 ± 3.43E-03 13.22 ± 8.46E-03 13.29 ± 6.41E-03 12.16 ± 4.26E-03 11.42 ± 5.37E-03 11.06 ± 5.26E-03 
18:1 trans 0.15 ± 1.61E-04 0.20 ± 7.30E-05 0.19 ± 1.33E-04 0.17 ± 1.41E-04 0.12 ± 9.60E-05 0.12 ± 1.18E-04 
18:1 (ω-9) 19.25 ± 1.13E-03 19.26 ± 3.28E-03 19.28 ± 2.47E-03 18.03 ± 3.50E-03 18.37 ± 1.10E-03 18.60 ± 3.24E-03 
18:2 (ω-6) trans 0.16 ± 1.69E-04 0.17 ± 5.55E-05 0.18 ± 8.65E-05 0.15 ± 1.74E-04 0.12 ± 1.32E-04 0.09 ± 5.12E-05 
18:2 (ω-6) 7.23 ± 4.16E-03 6.48 ± 3.01E-03 6.93 ± 6.29E-03 8.60 ± 2.37E-03 8.60 ± 4.96E-03 8.38 ± 3.45E-03 
18:3 (ω-6) 0.06 ± 1.63E-05 0.07 ± 4.78E-05 0.06 ± 2.44E-05 0.05 ± 2.04E-05 0.04 ± 3.78E-05 0.03 ± 1.24E-05 
18:3 (ω-3) 0.06 ± 9.22E-05 0.09 ± 1.12E-04 0.11 ± 1.94E-04 0.10 ± 1.33E-04 0.07 ± 7.35E-05 0.06 ± 5.85E-05 
20:0 0.17 ± 2.49E-04 0.18 ± 2.39E-04 0.19 ± 2.41E-04 0.17 ± 2.08E-04 0.15 ± 2.62E-04 0.15 ± 3.14E-04 
20:1 (ω-9) 0.53 ± 4.60E-04 0.60 ± 7.71E-04 0.59 ± 5.01E-04 0.41 ± 4.13E-04 0.35 ± 3.17E-04 0.32 ± 1.60E-04 
20:2 (ω-6) 0.15 ± 2.08E-04 0.15 ± 1.39E-04 0.16 ± 1.45E-04 0.14 ± 3.79E-05 0.13 ± 3.35E-05 0.13 ± 3.94E-05 
20:3 (ω-6) 1.39 ± 9.94E-04 1.14 ± 5.33E-04 1.12 ± 6.92E-04 1.16 ± 7.24E-04 1.14 ± 5.54E-04 1.17 ± 4.38E-04 
20:4 (ω-6) 20.89 ± 5.15E-03 20.02 ± 2.22E-03 20.04 ± 3.07E-03 4.98 ± 2.56E-03 4.87 ± 1.70E-03 5.19 ± 1.67E-03 
20:5 (ω-3) 0.04 ± 5.35E-05 0.05 ± 4.78E-05 0.05 ± 5.37E-05 2.31 ± 2.64E-03 2.42 ± 2.39E-03 2.12 ± 2.04E-03 
22:0 0.14 ± 8.81E-05 0.11 ± 1.72E-04 0.12 ± 2.92E-05 0.12 ± 1.26E-04 0.08 ± 7.58E-05 0.08 ± 1.09E-04 
22:4 (ω-6) 2.20 ± 5.21E-04 2.43 ± 6.08E-04 2.53 ± 6.55E-04 0.16 ± 8.58E-05 0.14 ± 2.16E-04 0.12 ± 5.39E-05 
22:5 (ω-6) 3.90 ± 1.87E-03 4.10 ± 4.68E-03 3.75 ± 3.50E-03 0.05 ± 2.53E-05 0.04 ± 6.57E-05 0.03 ± 3.20E-05 
22:5 (ω-3) 0.11 ± 1.09E-04 0.11 ± 7.65E-05 0.12 ± 1.64E-04 0.60 ± 3.04E-04 0.61 ± 2.72E-04 0.58 ± 1.97E-04 
22:6 (ω-3) 2.44 ± 1.38E-03 2.27 ± 1.99E-03 2.39 ± 1.36E-03 18.29 ± 4.27E-03 18.39 ± 2.99E-03 18.30 ± 3.82E-03 
24:0 0.24 ± 1.84E-04 0.25 ± 1.85E-04 0.26 ± 1.63E-04 0.32 ± 2.52E-04 0.24 ± 4.73E-04 0.18 ± 1.05E-04 
24:1 (ω-9) 0.37 ± 2.56E-04 0.39 ± 8.12E-04 0.39 ± 4.96E-04 0.35 ± 4.11E-04 0.22 ± 3.81E-04 0.20 ± 2.77E-04 
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Figure 26. Fatty acid analysis within red blood cells for therapeutic semi-acute & chronic 
models. Percentage of DHA content between control and 1% DHA diet for (A) semi-acute 
and (B) chronic exposure models. Data presented as mean ± SEM, n=4. ++++P<0.0001 
compared to different treatments within the same exposure group. Analyses were done with 
log-transformed data. 
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weeks (chronic) after the last particle instillation. After termination of the two scenarios, 
the mice were extensively evaluated to determine particle effects with and without DHA. 
Confirmation of fatty acid composition within red blood cells was sent for analysis (semi-
acute; Table 5, and chronic; Table 6) which confirmed an increase in DHA content within 
the DHA-fed mice compared to the control diet for both exposure models (Figure 26). 
Whole lung lavages were performed in order to collect immune cells that reside within the 
lungs and assess inflammatory responses. 
Overall in the semi-acute model, the mice had a dominant increase in alveolar 
macrophages (AM) regardless of diet and particle exposure (Figure 27A). Mice exposed to 
SiO2 also had a slight increase in neutrophils compared to the other exposure groups. 
Cellular toxicity was determined by assessing LDH levels (indicative of overall pulmonary 
cell damage; Figure 27B) and protein concentration (marker for epithelial cell damage; 
Figure 27C), within the lung lavage fluid (LLF). Mice on the DHA diet and exposed to 
DM-only had lower background levels of lung injury markers when compared to DM-only 
control diet mice indicating that DHA had a protective effect on basal health status. Mice 
exposed to either MWCNT or SiO2 and treated with DHA had less overall cellular damage 
within the lungs as indicated by LDH levels. However, there was a trending increase of 
epithelial damage for both particle exposures with DHA treatment when compared to 
control mice (Figure 27 B,C). Since there was a mixture of results for cellular toxicity with 
DHA treatment, both inflammatory and pro-resolving cytokines were assessed within the 
LLF to determine the effects of particles and DHA treatment on signaling responses (Figure 
28). Mice exposed to MWCNT with DHA treatment had a  
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Figure 27. Pulmonary cells and lung injury analysis in therapeutic semi-acute model. 
Balb/c mice were instilled once with either DM, MWCNT, or SiO2 at week 0, kept on the 
normal mouse chow for 1 week, and then put on either a control or 1% DHA diet for 3 
weeks. (A) Percentage of cell types were assessed via cytospins. (B) LDH and (C) protein 
concentration were assessed in the LLF for lung damage. Data presented as mean ± SEM, 
n=4-6. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to DM, + compared to 
different diet within the same exposure group. Analyses were done with log-transformed 
data. 
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Figure 28. Cytokine analysis in therapeutic semi-acute model. Balb/c mice were instilled 
once with either DM, MWCNT, or SiO2 at week 0, kept on the normal mouse chow for 1 
week, and then put on either a control or 1% DHA diet for 3 weeks. Inflammatory 
cytokines; IFN-γ, IL-1β, TNFα, IL-33, pro-resolving cytokines; IL-10, and IL-13, and IL-
6 were analyzed in the LLF. Data presented as mean ± SEM, n=4-6. *P<0.05, **P<0.01, 
****P<0.0001 compared to DM, + compared to different diet within the same exposure 
group. Analyses were done with log-transformed data. 
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significant decrease in TNFα levels; however, IL-1β and IL-33 levels were increased 
(Figure 28). For the pro-resolving mediators, DHA treatment increased IL-10 and IL-13 
levels when mice were exposed to MWCNT compared to the control diet-fed mice. Mice 
exposed to SiO2 with DHA treatment had an overall increase of inflammatory cytokines 
compared to control diet-fed mice (Figure 28). These results showed that mice with a semi-
acute particle exposure to MWCNT while on a therapeutic 1% DHA diet had decreased 
lung injury compared to the control diet; however, there was increased lung damage when 
mice were exposed to SiO2 while on the same DHA diet which supported the hypothesis. 
 In the chronic exposure model, there were also predominantly AM present 
regardless of exposure group as well as a small increase in lymphocytes (Figure 29A). Mice 
exposed to MWCNT and treated with DHA had a trending decrease of overall cellular 
damage as assessed by LDH levels (Figure 29B) within the LLF, but there was a slight 
increase in epithelial cell damage as indicated by protein concentration (Figure 29C). This 
corresponded with decreased inflammatory cytokine levels within the LLF with a slight 
increase of IL-33 levels for mice exposed to MWCNT and treated with DHA (Figure 30). 
Exposure to SiO2 had increased neutrophils and eosinophils in addition to AM and 
lymphocytes for both diets (Figure 29A). This corresponded to increased cellular toxicity; 
indicated by a significant increase in LDH levels (Figure 29B) and a slight increase in 
protein concentration (Figure 29C), within the LLF of mice on the DHA diet compared to 
control diet mice. Mice exposed to SiO2 and treated with DHA also had overall increased 
inflammatory cytokine levels and decreased pro-resolving cytokine  
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Figure 29. Pulmonary cells and lung injury analysis in therapeutic chronic model. Balb/c 
mice were instilled with either DM, MWCNT, or SiO2 once a week at weeks 0, 1, 2, 3 
while on the normal mouse chow and at week 4 were put on a control or 1% DHA diet for 
12 weeks. (A) Percentage of cell types were assessed via cytospins. (B) LDH and (C) 
protein concentration were assessed in the LLF for lung damage. Data presented as mean 
± SEM, n=4-7. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to DM, + compared 
to different diet within the same exposure group. Analyses were done with log-transformed 
data. 
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Figure 30. Cytokine analysis in therapeutic chronic model. Balb/c mice were instilled with 
either DM, MWCNT, or SiO2 once a week at weeks 0, 1, 2, 3 while on the normal mouse 
chow and at week 4 were put on a control or 1% DHA diet for 12 weeks. Inflammatory 
cytokines; IFN-γ, IL-1β, TNFα, IL-33, pro-resolving cytokines; IL-10, and IL-13, and IL-
6 were analyzed in the LLF. Data presented as mean ± SEM, n=4-7. *P<0.05, **P<0.01, 
***P<0.001, ****P<0.0001 compared to DM, + compared to different diet within the same 
exposure group. Analyses were done with log-transformed data. 
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levels within the LLF when compared to mice on the control diet (Figure 30). These results 
indicated that mice on the therapeutic 1% DHA diet with a chronic particle exposure to 
MWCNT had less lung damage compared to the control-fed mice; however, the same DHA 
treatment was not protective for SiO2-exposed mice which also supported the hypothesis. 
 
5.3.2 Alteration of LMP due to DHA 
As described above, AM were predominantly present within the LLF of the mice; 
regardless of exposure group, for both the semi-acute and chronic exposure models. 
Pulmonary macrophages are responsible for maintenance of homeostatic conditions within 
the lungs. This includes regulating immune responses to inhaled foreign materials; such as 
exposure to MWCNT or SiO2, by phagocytosing these foreign substances and processing 
them for elimination. However, these environmental stimuli can cause lysosomal damage 
which can lead to phagolysosomal membrane permeability (LMP) where various 
lysosome-specific proteases; such as cathepsins, are released into the cytosol. Activation 
of the NLRP3 inflammasome by these proteases, cathepsin B in particular, can occur and 
ultimately IL-1β release ensues which results in various inflammatory cascades (Schroder 
& Tschopp, 2010; Strowig et al., 2012). Therefore, the effects of DHA on LMP were 
assessed in order to determine if DHA had impacted the stability of the phagolysosmal 
membrane. AM were isolated from the LLF and cultured ex vivo in order to assess IL-1β 
release specifically from AM. Total cathepsin and cathepsin B levels; lysosome-specific 
proteases, were measured within the LLF as well. 
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Figure 31. Assessment of LMP in therapeutic semi-acute model. Balb/c mice were instilled 
once with either DM, MWCNT, or SiO2 at week 0, kept on the normal mouse chow for 1 
week, and then put on either a control or 1% DHA diet for 3 weeks. LMP was assessed 
through detection of (A) IL-1β release directly from AMs ex vivo, (B) cathepsin release 
within the LLF, and (C) cathepsin B release within the LLF. Data presented as mean ± 
SEM, n=3-6. *P<0.05, ***P<0.001 ****P<0.0001 compared to DM, + compared to different 
diet within the same exposure group. Analyses were done with log-transformed data. CTS; 
cathepsin. 
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 In the semi-acute exposure model, mice exposed to DM-only and treated with DHA 
had decreased levels of all LMP markers compared to control diet-fed mice (Figure 31) 
indicating that DHA improved the stability of the phagolysosomal membrane for basal 
health. Mice exposed to MWCNT while on the DHA diet had a significant decrease of IL-
1β release ex vivo from AM (Figure 31A); however, there was a slight increase of total 
cathepsin levels (Figure 31B) and no change between diets for cathepsin B release (Figure 
31C) within the LLF. SiO2-exposed mice had a trending increase of IL-1β release ex vivo 
from AM (Figure 31A) with no change between diets for total cathepsin release (Figure 
31B), but decreased cathepsin B levels within the LLF (Figure 31C) when compared to 
control-fed mice. These results suggested that mice on the therapeutic 1% DHA diet had 
improved phagolysosomal membrane stability for background AM; however, results 
varied depending on particle exposure within the semi-acute model. DHA treatment 
appeared to be protective later in the LMP pathway since there was less IL-1β release for 
MWCNT-exposed mice. Mice exposed to SiO2 with DHA treatment had a protective effect 
on cathepsin B release; however, protease leakage still occurred and resulted in increased 
inflammatory signaling when compared to control mice. 
Results from the chronic exposure model showed decreased levels of all LMP 
markers for DM-only exposed mice with DHA treatment compared to control diet-fed mice 
(Figure 32) indicating improved phagolysosomal membrane stability similar to the semi-
acute model for basal health. Mice exposed to MWCNT and treated with DHA had 
decreased release of IL-1β ex vivo from AM (Figure 32A) and a slight decrease for total 
cathepsin levels in the LLF (Figure 32B) when compared to the control mice, but there was 
no change between diets for cathepsin B levels (Figure 32C). SiO2-exposed mice  
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Figure 32. Assessment of LMP in therapeutic chronic model. Balb/c mice were instilled 
with either DM, MWCNT, or SiO2 once a week at weeks 0, 1, 2, 3 while on the normal 
mouse chow and at week 4 were put on a control or 1% DHA diet for 12 weeks. LMP was 
assessed through detection of (A) IL-1β release directly from AMs ex vivo, (B) cathepsin 
release within the LLF, and (C) cathepsin B release within the LLF. Data presented as 
mean ± SEM, n=4-7. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001 compared to DM, + 
compared to different diet within the same exposure group. Analyses were done with log-
transformed data. CTS; cathepsin. 
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with DHA treatment had a significant decrease of IL-1β release ex vivo from AM (Figure 
32A); however, there were increased levels of both total cathepsin and cathepsin B within 
the LLF (Figure 32 B,C) when compared to control diet-fed mice. These results indicated 
that mice within the chronic exposure model on the therapeutic 1% DHA diet and exposed 
to DM-only or MWCNT had improved phagolysosomal membrane stability. Mice exposed 
to SiO2 with DHA treatment had decreased phagolysosomal membrane stability; however, 
DHA was protective by decreasing AM inflammatory signaling. This supported the 
hypothesis that DHA treatment decreased pulmonary inflammatory markers in response to 
particle-induced inflammation which was more effective in treating MWCNT- than SiO2-
exposed mice. 
 
5.3.3 DHA shifts macrophage phenotype 
Recent in vivo particle-exposure studies in our laboratory using 1% DHA as a prophylactic 
treatment demonstrated that mice on the DHA diet shifted macrophage phenotype towards 
the pro-resolving phenotypes. Various signaling factors; such as cytokines and immune 
complexes, generate different macrophage phenotypes that are broadly defined as either 
classically activated, “pro-inflammatory” M1 or alternatively activated, “anti-
inflammatory” M2. However, a spectrum of macrophage phenotypes is always present 
which could be representing hybrid phenotypes rather than individually-defined 
phenotypes. Extracellular and intracellular signaling factors determine which macrophage 
phenotype is dominant to regulate the overall response. Depending on the overall 
environment, macrophages could either be aiding in inflammation or suppressing 
inflammation through phenotype shifts (Byrne et al., 2015; Italiani & Boraschi, 2014; 
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Labonte et al., 2014). It is important to understand that this is a snap-shot in time to assess 
the shifts in phenotypes between particle exposure as well as DHA treatment groups at 
these particular timepoints. Assessing the effects of DHA on macrophage phenotype when 
exposed to various particles is lacking in the current literature; especially when analyzing 
the M2b and M2c subsets. Therefore, macrophage phenotypes were assessed within the 
lung and spleen tissues using sixteen known gene markers in order to determine if exposure 
to particles caused phenotype shifts and if DHA treatment impacted these alterations. 
Spleen tissue was included for evaluation in this portion of the study since our laboratory 
has recently shown trafficking of MWCNT into the spleen resulting in changes of immune 
cell populations. 
 In the lung tissue of the semi-acute exposure model, there was a dominant 
downregulation of overall gene expression for macrophage phenotype markers for both 
MWCNT and SiO2-exposed mice when the effect of particle-only exposure was assessed 
compared to DM-only exposed mice (Figure 33A). The DHA diet altered this gene 
expression within the lung tissue by bringing most of those same genes closer to baseline 
levels (Figure 33B). Mice exposed to DM-only had a trending upregulation of the M2b 
phenotype as indicated by an upregulation of two of the four genes with DHA treatment. 
There were dominant baseline gene expression levels of the M2c phenotype for mice 
exposed to DM-only while on the DHA diet which indicated that these gene expressions 
were similar for both control- and DHA-fed mice (Figure 33B). However, this was not the 
case for mice exposed to either particle upon DHA treatment which were mostly 
downregulated changes in gene expression and some baseline values instead (Figure 33B). 
Gene expression within the spleen tissue had a dominant downregulation of overall  
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Figure 33. Impact of particle exposure and DHA treatment on macrophage phenotype in 
therapeutic semi-acute model. Balb/c mice were instilled once with either DM, MWCNT, 
or SiO2 at week 0, kept on the normal mouse chow for 1 week, and then put on either a 
control or 1% DHA diet for 3 weeks. Relative gene expression of control diet MWCNT or 
SiO2 mice were normalized to control diet DM mice for assessment of particle effect in (A) 
lung and (C) spleen tissue. Relative gene expression of 1% DHA diet mice were normalized 
to corresponding control diet mice for assessment of diet effect in (B) lung and (D) spleen 
tissue. Each bar within the heat maps consist of 5-7 mice for lung tissue and 4-5 mice for 
spleen tissue. 
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macrophage phenotype markers for MWCNT-exposed mice (Figure 33C). There was a 
trending upregulation in the M2a markers for SiO2-exposed mice; however, it was not 
enough to describe it as a dominant macrophage phenotype shift (Figure 33C). Upon DHA 
treatment within the spleen tissue, there were minor gene expression shifts; however, the 
DHA diet did not alter the overall gene expression of macrophage phenotype markers 
within the spleen tissue when compared to the particle-only effect (Figure 33D). DHA 
treatment did downregulate the trending M2a gene expression of the particle-only effect 
observed for the SiO2-exposed mice in the spleen tissue (Figure 33D). These results 
indicated that particle-exposed mice on a therapeutic 1% DHA diet did not have dominant 
macrophage phenotype effects in a semi-acute model; however, DHA treatment brought 
gene expression levels closer to baseline within the lung tissue. 
 The particle-only effect in the lung tissue of the chronic particle exposure model 
had an overall downregulation of gene expression within most of the macrophage 
phenotype markers, regardless of particle exposure (Figure 34A). Upon DHA diet 
treatment, there was a general downregulation of gene expression throughout the 
macrophage phenotype markers regardless of treatment group for the lung tissue (Figure 
34B). There was a trending upregulation of the M2b phenotype with SiO2-exposed mice 
within the lung tissue with DHA treatment; however, not enough to indicate it as a 
dominant phenotype shift (Figure 34B). The spleen tissue assessment of the particle-only 
effect showed a dominant upregulation of the M2c phenotype for both MWCNT- and SiO2-
exposed mice when compared to DM-only mice as indicated by upregulation of at least 
three of the four genes (Figure 34C). DHA treatment altered these responses within  
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Figure 34. Impact of particle exposure and DHA treatment on macrophage phenotype in 
therapeutic chronic model. Balb/c mice were instilled with either DM, MWCNT, or SiO2 
once a week at weeks 0, 1, 2, 3 while on the normal mouse chow and at week 4 were put 
on a control or 1% DHA diet for 12 weeks. Relative gene expression of control diet 
MWCNT or SiO2 mice were normalized to control diet DM mice for assessment of particle 
effect in (A) lung and (C) spleen tissue. Relative gene expression of 1% DHA diet mice 
were normalized to corresponding control diet mice for assessment of diet effect in (B) 
lung and (D) spleen tissue. Each bar within the heat maps consist of 5-7 mice for lung 
tissue and 4-6 mice for spleen tissue. 
 
 
 112 
the spleen tissue via a dominant downregulation of gene expression levels of almost all of 
the macrophage phenotype markers regardless of particle group (Figure 34D). These 
results indicated that a therapeutic 1% DHA diet for chronic particle-exposed mice did not 
have a dominant macrophage phenotype shift within the lung tissue; however, DHA 
downregulated gene expression within the spleen tissue. 
 
5.3.4 Effect of DHA on lung histopathology 
The therapeutic 1% DHA treatment affected inflammatory signaling cascades for both the 
semi-acute and chronic particle exposure models. Therefore, investigation of DHA’s 
impact on particle-induced inflammation for lung pathology was assessed. Lung tissue 
sections were trichrome-stained and scored for histological analysis. The degree of lung 
inflammation was scored on a 5-point scale system (0, 1, 2, 3, 4) with 0 being no effect and 
4 indicating extreme lung inflammation. Airway thickness was also examined since recent 
studies in our laboratory using 1% DHA as a prophylactic treatment indicated particle-
induced airway thickening. 
 Mice on the DHA diet and exposed to DM-only in the semi-acute model had a small 
increase in lung inflammation compared to control diet-fed mice (Figure 35A), but there 
was no difference between diets for airway thickness (Figure 35B). Both the MWCNT- 
and SiO2-exposed mice had minor differences for both the pathology and airway thickness 
analyses; however, no significant differences were observed between the diets. 
Representative photomicrographs of these findings are shown in Figure 35C. 
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Figure 35. Histopathology analysis of lung tissue in therapeutic semi-acute model. Balb/c 
mice were instilled once with either DM, MWCNT, or SiO2 at week 0, kept on the normal 
mouse chow for 1 week, and then put on either a control or 1% DHA diet for 3 weeks. 
Pathology was scored blinded by two observers; data presented as median ± SEM (A). 
Airway thickness was measured blinded; data presented as mean ± SEM (B).  
Representative images (10x) of Masson’s trichrome-stained lung airway sections (C). n=3;  
**P<0.01 compared to DM. Arrows indicate particle encapsulation, blue staining indicates 
collagen deposition. 
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Figure 36. Histopathology analysis of lung tissue in therapeutic chronic model. Balb/c 
mice were instilled with either DM, MWCNT, or SiO2 once a week at weeks 0, 1, 2, 3 
while on the normal mouse chow and at week 4 were put on a control or 1% DHA diet for 
12 weeks. Pathology was scored blinded by two observers; data presented as median ± 
SEM (A). Airway thickness was measured blinded; data presented as mean ± SEM (B).  
Representative images (10x) of Masson’s trichrome-stained lung airway sections (C). n=3;  
*P<0.05, **P<0.01, ***P<0.001 compared to DM, + compared to different diet within the 
same exposure group. Arrows indicate particle encapsulation, arrow head indicates 
increased lung airway thickness, and blue staining indicates collagen deposition. 
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These results suggested that a therapeutic 1% DHA treatment had limited effects on 
particle-induced inflammation and overall lung pathology for a semi-acute particle 
exposure model. 
 For the chronic exposure model, mice exposed to MWCNT and treated with DHA 
had a slight decrease of pulmonary inflammation, but no difference for airway thickness 
when compared to control diet-fed mice (Figure 36 A,B). There was no difference between 
diets for pulmonary inflammation of SiO2-exposed mice, but there was significantly 
increased airway thickness for mice on the DHA diet. Representative photomicrographs of 
these findings are shown in Figure 36C. These results indicated that a therapeutic 1% DHA 
treatment had a minor impact on a chronic MWCNT exposure. A chronic exposure to SiO2 
increased inflammation regardless of diet and DHA was not beneficial for lung 
histopathology for this particle exposure. 
 
5.4 Discussion  
Research of how DHA; an omega-3 PUFA reported to have anti-inflammatory capabilities, 
affects particle-induced lung inflammation is currently limited. Our laboratory had 
previously assessed if DHA could be used as a potential prophylactic treatment for particle-
induced inflammation. Those results showed that DHA treatment was more beneficial for 
a nano-sized MWCNT exposure than a micron-sized SiO2 exposure which may be linked 
to phagolysosomal membrane stability and macrophage phenotype shifts. Most research is 
assessing the impacts of DHA as a potential prophylaxis; however, therapeutic treatments 
are lacking for particle-induced inflammatory diseases as well. The goal of this chapter 
was to assess if DHA could potentially assist with treatment; specifically, pulmonary 
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inflammation induced by MWCNT or SiO2 in semi-acute and chronic exposure models. 
Therefore, inflammatory signaling within the LLF, lung histopathology analysis, the 
occurrence of LMP, and macrophage phenotype shifts were analyzed to address this issue. 
 Current analysis of inflammatory mediators in the LLF demonstrated that a 
therapeutic 1% DHA treatment had varying results between the particle exposure models. 
This continual variance of DHA’s impact between the two different types of particles could 
be linked to various physiochemical particle characteristics. These variables could be due 
to particle morphology, size, surface charge, or composition. MWCNT are hydrophobic 
man-made rolled graphene sheets in the size range of 1–100 nm in at least one dimension 
with a high surface area per mass (Saifuddin et al., 2013). SiO2, on the other hand, is 
considered hydrophilic and commonly found in nature as quartz which can be fractured to 
a respirable size of <10 μm (Dyachenko et al., 2004; Pollard, 2016). Overall, DHA 
treatment appeared to be more protective after the MWCNT exposure rather that SiO2 
exposure which supported our hypothesis. When assessing toxicity and cytokine 
production in the LLF, LDH levels as well as IFNγ and TNFα levels were consistently 
decreased upon DHA treatment for MWCNT-exposed mice. This trend continued when 
LMP markers were assessed. Mice exposed to MWCNT while on the DHA diet had a 
decrease in IL-1β release ex vivo for both studies as well as a trending decrease of total 
CTS levels within the LLF for the chronic exposure model. Furthermore, there was a 
trending decrease in pulmonary inflammation within the chronic exposure model upon 
DHA treatment with mice exposed to MWCNT. The length of the DHA treatment appeared 
to contribute to the varying particle effects within the Balb/c mice as well. 
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There was a consistency throughout the studies where prolonged treatment of DHA 
was more promising for the exposure groups. Both the basal health levels; as indicated by 
the DM-only exposed, and the MWCNT-exposed mice had more decreased levels of 
inflammatory cytokines in the LLF upon DHA treatment for the chronic exposure model. 
The differences seen between the length of DHA treatment for particle effects may partially 
be due to the time it takes for DHA to equilibrate into the phospholipids. Therefore, when 
DHA is used as a therapeutic treatment the particle-induced inflammation can persist for a 
few weeks before beneficial effects of DHA treatment are observed. Consequently the 
current semi-acute model may have required a longer timepoint for DHA treatment as a 
therapeutic in order to see more beneficial effects. The extended incorporation of DHA 
into phospholipids could alter lipid packing and membrane raft structure in lysosomal 
membranes which could affect membrane stability and LMP (Turk and Chapkin, 2013; 
Wassall et al., 2018). When comparing the two exposure models there were also more LMP 
markers decreased upon DHA treatment for the chronic model. This observation continued 
when macrophage phenotype was assessed which indicated a downregulation of gene 
expression in the spleen tissue with DHA treatment in the chronic particle-exposure study. 
These results demonstrated that prolonged treatment of DHA; especially when exposed to 
MWCNT, had the best outcome rather than the semi-acute model which supported the 
hypothesis. The protective mechanisms of DHA as a therapeutic treatment were still 
unclear; however, future assessments of DHA’s impact on macrophage metabolism and 
autophagy should be done in order to determine these potential capabilities. 
Various key functions of macrophages are related to singular metabolic signatures 
(Stunault et al., 2018). There is an association between PM2.5 exposure and increased 
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incidence of metabolic syndrome-related diseases (R. Li et al., 2016). The metabolic 
pathways are different between the macrophage phenotypes. M1 macrophages are 
associated with glycolysis, disrupted Krebs cycle, and ROS production while M2a 
macrophages are linked to fatty acid oxidation, lipolysis, and glutaminolysis (Stunault et 
al., 2018). Macrophage deletion of Ascl1; which is an enzyme involved in fatty acid 
synthesis, is associated with decreased IL-1β and TNFα (Stunault et al., 2018). In the 
present chronic particle-exposure model, there were decreased levels of both of those 
cytokines within the LLF after DHA treatment. The NLRP3 inflammasome regulates 
glycolysis and M1 macrophages have increased glycolysis (Finucane et al., 2019). The 
current results showed an increase in various M1-associated genes for chronic particle 
exposure which were downregulated upon DHA treatment. However; it has been 
speculated that DHA could be exerting anti-inflammatory effects through preventing 
macrophage activation (Ali et al., 2016) which correlated with the current semi-acute 
particle-exposure model where there was minimal macrophage phenotype shifts. This 
suggested that longer exposure of DHA treatment as a therapeutic may be more beneficial 
for particle-induced inflammation.  
It has been suggested that M2 macrophage activation may be associated with 
increased fatty acid oxidation and mitochondrial biogenesis (Benmoussa et al., 2018). One 
study reported that a fish oil diet improved mitochondrial function (Shen et al., 2017). It 
has been reported that the removal of damaged mitochondria via autophagy as well as the 
inhibition of fatty acid synthase decreased NLRP3 inflammasome activation and IL-1β 
secretion (Benmoussa et al., 2018). However, it has been suggested that impaired lysosome 
function blocks autophagy (Saitoh et al., 2008). The current results showed that DM-only 
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exposed mice with DHA treatment had decreased total cathepsin, cathepsin B, and IL-1β 
levels which indicates increased stability of the phagolysosomal membrane. Exposure to 
particles slightly altered these results which could imply impaired lysosome function; 
however, the particle-exposed mice were slightly protected upon DHA treatment. One 
study reported that DHA increased autophagosome formation within bone marrow-derived 
macrophages (Williams-Bey et al., 2014) while another study suggested that DHA-induced 
activation of p38 MAPK in U937 cells was related to autophagy (Kawano et al., 2019). It 
has been shown that SiO2-exposed autophagy-deficient mice had increased lung pathology 
(Jessop et al., 2016) and the current studies revealed that mice treated with DHA had some 
decreased lung pathology compared to control diet-fed mice. It would be interesting to 
assess the impacts of DHA on autophagy within a particle-exposure model. 
Taken together, the current results indicated that a therapeutic 1% DHA treatment 
has the potential to be beneficial for particle-induced inflammation; however, it did not 
appear to be as effective as using it as a potential prophylaxis. These results implied that 
DHA was more protective as a therapeutic treatment in a chronic particle-exposure model; 
especially for MWCNT exposure. This could be linked to the time it takes for DHA to 
become incorporated into phospholipids in order to stabilize the phagolysosomal 
membrane as well as shifts in macrophage phenotype formation with alterations of 
macrophage metabolism or autophagy. Exposure to SiO2 with DHA treatment was not as 
consistent throughout the exposure studies; however, there were several promising 
outcomes. DHA could potentially be used as a therapeutic treatment for particle-induced 
inflammation, but should be researched further to assess the impacts on autophagy and 
metabolism since these results are not fully understood. 
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